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Molecular imaging, the non-invasive visualization of cellular and sub-cellular events, holds 
great promise to improve the basic understanding of biochemical processes and clinical diagnosis 
of diseases. One widely used molecular imaging technique is positron emission tomography 
(PET) that is especially useful for clinical oncology applications. PET has seen remarkable 
growth recently due to improvements in the regulation of PET radiotracers and the development 
of multimodal imaging set-ups that combine the sensitivity of PET with X-ray computed 
tomography (CT) or magnetic resonance imaging (MRI) that provide anatomical details. To date 




F]FDG). Despite the 




F has a short half-life and [
18
F]FDG cannot detect certain cancers. 
There is a desire to develop radiometal-based radiotracers that have a wide selection of 
radioisotope half-lives from 10’s of minutes to days. Additionally, these tracers have the 
potential for flexible synthesis of tumor-specific tracers by easily changing the biomolecule 
(BM) utilized. However, radiometal-based PET radiotracers still face key challenges including 
(1) site-specific attachment of bifunctional chelators (BFCs), responsible for chelating the 
radiometal, to tumor-targeting biomolecules and (2) improving synthesis equipment to reduce 
reagent use and radiation shielding costs. 
My dissertation primarily focuses on addressing the challenges associated with radiometal-
based PET radiotracer synthesis. “Click chemistry”, or more specifically Cu(I)-catalyzed azide-
alkyne cycloaddition (CuAAC), was utilized to address the concern regarding site-specific 
attachment of BFCs to BMs. CuAAC, like other “click reactions”, yields products with few side 
reactions under mild reaction conditions which is key when working with biomolecules. 
However, PET radiotracers are typically made in small batches because radioisotopes are 
iii 
 
utilized. Microfluidic platforms enable handling of small volumes, reducing reagent use and 
simultaneously minimizing radiation shielding costs due to their inherently small size. Here I 
describe how microfluidics was merged with the “click chemistry” concept to produce BM-BFC 
conjugates with the potential to be used as PET radiotracers. In Chapter 2 I describe the initial 
development and fabrication of a “click chip” with immobilized Cu(I) catalyst to facilitate 
CuAAC reactions that also minimizes purification requirements because the cytotoxic Cu(I) 
catalyst is immobilized to the microfluidic platform. Chapter 3 discusses how the “click chip” 
was improved to reduce solvent loss and enable longer reactions to conjugate BMs and BFCs. 
Nanoparticles (NPs) are another class of imaging agents that have some advantages over small 
molecule-based imaging agents (e.g., facile incorporation of multiple imaging modalities). 
However, many NPs are synthesized using low-yield synthetic strategies not amenable for scale 
up (e.g., microfluidics). Microfluidic mixers have been well characterized over the past decades, 
but few efforts have focused on millifluidic mixers and millifluidic platforms in general. 
Millifluidic devices offer some of the same advantages as microfluidics, such as rapid heat and 
mass transfer, but also enable higher throughput and are typically easier to fabricate. In Chapter 
4 I discuss the design and fabrication of a millifluidic mixer that was validated by synthesizing 
gold nanoparticles (AuNPs). 
Ultimately, I was able to develop microfluidic and millifluidic platforms that have the 
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Molecular imaging can broadly be defined as the noninvasive visualization of biochemical 
processes on the sub-cellular and cellular levels, but the specifics of what molecular imaging 
entails can differ depending on the field.
1
 Molecular imaging continues to improve the 
understanding of basic biochemistry and cell biology as well as clinical diagnostics and disease 
treatment. A primary motivation of molecular imaging is to overcome the limitations of standard 
in vitro assays by moving to an in vivo setting.
1
 Some advantages of molecular imaging 
compared to traditional in vitro assays include (1) noninvasively studying cells in their natural 
environment in real-time
2
, (2) capable of performing repeated studies with the same animal, 
enabling collection of longitudinal data
3, 4
, and (3) rapidly determining pharmacokinetics and 
pharmacodynamics of new drug candidates reducing time and cost for drug development
4
. Key 
molecular imaging agent modalities include X-ray computed tomography (CT), positron 
emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic 
resonance imaging (MRI), and ultrasound (US). The choice of imaging modality/modalities 
depends on a number of criteria such as required spatial resolution, requisite sensitivity 
(minimum imaging agent concentration necessary for detection), and whether a whole body or 
only a small region needs to be imaged.
1, 5
 
Two of the aforementioned imaging techniques, PET and SPECT, require administering 
radioisotope-based imaging probes into the subject/sample and detecting the decaying isotopes. 
These radioisotope indicators, typically with the radioisotope incorporated into a biologically 
active compound, are also known as radiotracers.
6
 Radiotracers have proven particularly adept 
2 
 
for clinical oncology applications because (1) only minute concentrations (as low as picomolar) 
of imaging probes are required compared to concentrations of contrast agents for other molecular 
imaging modalities such as CT (~millimolar) or MRI (~micromolar)
7
 and (2) radiotracers are 
able to specifically target tumors. Radiotracer specificity for particular tumors is accomplished 









 into the radiotracers to either target overexpressed surface receptors on cells, or 
abnormal tumor metabolism
13
 (e.g., excess glucose uptake). PET is particularly useful for 
oncology because PET has a higher sensitivity, higher resolution, and superior quantitative 
capability compared to SPECT.
15
 
1.1 History of PET radiotracers 
In the next few paragraphs I will present a brief history of PET and nuclear medicine in 
general to provide context on the future of PET radiotracers. A timeline (Figure 1.1) displays 
key dates for radiopharmaceuticals (including radiotracers) as well as “click chemistry” and 
microfluidics, which will be discussed in more detail in later sections in Chapter 1. There are 
several other sources available that discuss the history of nuclear medicine in more detail.
16-21
 
The birth of oncology imaging occurred in 1895 with the discovery of X-rays, and the first 
diagnostic radiotracer procedure performed on a human was in 1925, to measure circulation 
time.
16, 22
 A facile method to produce certain radionuclides was developed in 1931 by Ernest 
Lawrence when he invented the cyclotron. This was a key event for radiotracer production and 
nuclear medicine in general
23
, and the first cyclotron devoted to biomedical radionuclide 
production was built roughly a decade later at Washington University in St. Louis.
17
 Another 
important step in the development of PET and radiotracers occurred in 1951, when the first use 






Figure 1.1. A timeline that summarizes significant events for (1) radiopharmaceuticals (including radiotracers), (2) microfluidics, 
and (3) “click chemistry” with an emphasis on the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. The events in 




However, producing and using radioisotopes is only part of the equation. Methods to acquire 
images of radiotracers significantly advanced in 1963, when David Kuhl and Roy Edwards 
introduced emission reconstruction tomography, the precursor to PET, SPECT, and CT
16
, and the 







[F]FDG) was produced for the first time in 1976 as well
25
, and not 
only did 
18
[F]FDG help pave the way for PET use and research as discussed later in the 
regulation of PET radiotracers, 
18
[F]FDG is currently the most commonly used PET probe
26
. 
Initial clinical PET applications in the 1970s and 1980s focused on the field of neurology (e.g., 
evaluating brain function)
16
, and PET wasn’t extensively used clinically for oncology until the 
1990s.
27
 Over the last few decades, improvements in PET have come from multimodality 
imaging by combining PET and CT or PET and MRI. While PET is a highly sensitive molecular 
imaging technique, PET images lack the desired anatomical detail. Hence, PET/CT and 
PET/MRI equipment enables collection of complementary anatomic and biologic information 
that enhances localization of lesions.
28, 29
 
Another key aspect of the history and future of PET radiotracers is regulation, and for the 
purposes of this dissertation I will solely discuss regulation in the United States. PET 
radiotracers and production methods are unique compared to other pharmaceuticals for a number 
of reasons. First and foremost, because PET radiotracers have incorporated radioisotope(s) these 
probes require regulation as a drug and a radioactive compound. This distinction requires 
cooperation from multiple regulatory bodies and organizations in the United States including the 
Food and Drug Administration (FDA), the Nuclear Regulatory Commission (NRC), and the 
United States Pharmacopeia (USP). Additionally, many PET radiotracers have short half-lives 
requiring unique guidance on production and quality control.
18
 Similarly, because radiotracers 
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have high specificity, they are often administered in millimolar or micromolar concentrations to 
patients. At these concentrations PET radiotracers are well below toxic doses, and therefore 
require a different perspective regarding toxicology studies.
30
 Finally, from a cost standpoint two 
important factors to consider are (1) the importance of reimbursing PET procedures and (2) the 
expense of regulations on radiopharmacies producing PET radiotracers that are typically smaller 
than large pharmaceutical manufacturers.
19, 31
 
From a regulation standpoint, two of the major regulatory agencies involved are the FDA and 
NRC, formerly the Atomic Energy Commission (AEC) prior to splitting into the NRC and the 
current Department of Energy (DOE). Additionally, the USP is a nonprofit organization that fills 
an important role by developing and improving drug standards that the FDA enforces. The FDA 
and AEC/NRC regulate different aspects of radiopharmaceutical production and use, but since 
1975 the clinical use of all radiopharmaceuticals, including PET radiotracers, has been regulated 
by the FDA.
18
 As PET continued to develop, early PET centers (~1985-1998) were funded 
mostly by the National Institutes of Health (NIH) and DOE, but funding eventually became 
difficult to attain.
19
 In addition to funding challenges, expensive FDA regulations and lack of 
reimbursements for PET radiopharmaceuticals prevented further growth of PET.
31
 The FDA 
Modernization Act (FDAMA) was signed in 1997 to revamp the FDA and the agencies’ 
regulations, including PET radiotracer regulations. Separately, 
18
[F]FDG was approved by the 
FDA and the first reimbursements for 
18
[F]FDG occurred in 1998. These two events were vital 
for reducing cost of PET scans and led to a sudden growth in PET.
19, 30
 The FDAMA ultimately 
led to improved regulation of PET radiopharmaceuticals, including the creation of title 21 of the 
Code of Federal Regulations part 212 (21 CFR 212) that became effective in 2011
32
, and outlines 
current good manufacturing practice (CGMP) for PET radiopharmaceuticals. The regulatory 
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landscape for PET radiotracers played a critical role in the growth of PET radiotracers from the 
late 1990s to present, and also indicates the need of PET radiotracer production to meet the 
relatively new CGMP regulations. 
1.2 Conventional PET radiotracer synthesis 
Nuclear medicine has progressed significantly in the last ~90 years since the first diagnostic 
radiotracer procedure performed on a human in 1925. However, there are still many challenges 
with the production and use of radiopharmaceuticals, including PET radiotracers. As mentioned 






[F]FDG lacks the specificity to detect some types of tumors including liver, prostate, pancreas, 
and brain tumors.
33






C have short half-lives (< 2 h), limiting their use to smaller BMs that rapidly 
accumulate in tumors.
34
 Additionally, non-metal radioisotopes typically require complex 




Figure 1.2. A schematic showing the four main components, (1) biomolecule, (2) radiometal, (3) bifunctional chelator, and (4) 
linker, of a typical radiometal-based radiotracer. 
 






Ga have a wide range of half-lives on the order 
of 10’s of minutes to days and can easily be incorporated into tracers via a simple chelation 
event. Typical radiometal-based PET tracers consist of four main components: (1) a biomolecule 
to specifically target tumors, (2) a radiometal that emits positrons to enable imaging, (3) a 
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bifunctional chelator to bind the radiometal, and (4) a linker to covalently attach the BFC to the 
BM (Figure 1.2). Radiometal-based tracers are advantageous compared to radiotracers with non-
metal radioisotopes because radiometal-based radiotracers offer flexibility, modularity, and 
simplicity.
35
 Radiometal radiotracers are modular in the sense that BMs and BFCs can be 
conjugated in different combinations to provide the required tumor specificity by tuning the BM, 
while also enabling attachment of different radiometals by altering the BFC. The ability to 
change the BFC and associated radiometal provides flexibility to match the half-life of the probe 
to the half-life of the BM (i.e., adjust based on time for radiotracer to reach the target).
34
 Also, 
for smaller BMs (e.g., peptides) BFCs can affect the pharmacokinetics and biodistribution. The 
actual chelation of the radiometal to the BFC can be achieved under mild conditions and is 
typically simple to purify, unlike 
18
F-based probes which require harsh reaction conditions and 
complicated purifications.
35
 One key challenge with radiometal-based radiotracers is the site 
specific attachment of BFCs to BMs which is typically accomplished via amide, thiourea, and 
thioether bonds.
36
 However, biomolecules tend to have multiple free primary amines and thiols 
making site-specific BFC attachment a challenge.
37
 
While radiometal-based tracers offer unique advantages over 
18
F and other non-metal 
radiotracers, the production of radiometal PET tracers still faces challenges. Conventional 
radiotracer synthesis methods typically involve many tedious steps and impose constraints on 
conjugation reactions (i.e., conjugating BMs and BFCs), such as the requirement of 
protection/de-protection steps to prevent unwanted side reactions during conjugation reactions.
38
 
Additionally, commonly used radiopharmaceuticals are conventionally produced in automated 





 ASMs are expensive, require highly trained staff to operate, and due to their 
bulky size (~80 cm x 60 cm x 40 cm) require large amounts of space and radiation shielding.
41, 42
 
1.3 Addressing challenges in PET radiotracer synthesis 
Cu(I) “click chemistry” 
As mentioned previously, attachment of BFCs to BMs is typically accomplished via amide, 
thiourea, and thioether bonds.
36
 Yet these conjugation methods are challenging because the many 
functional groups present on BMs require protection/de-protection steps to prevent side 
reactions. In 2001 Kolb, Finn, and Sharpless outlined the concepts of “click chemistry” to 
describe reactions that chemoselectively form non-natural heteroatom links in high yields under 
simple reaction conditions.
43
 The most widely utilized “click” reaction, Cu(I)-catalyzed azide-
alkyne cycloaddition (CuAAC), was discovered in 2002 by two independent groups, Meldal in 
Denmark
44
, and Fokin and Sharpless
45
 in the United States.
46
 However, the origins of CuAAC 
date back to 1893 when the first 1,2,3-triazole was synthesized, and the reaction between azides 
and alkynes was examined further in the 1950s-1970s by Huisgen and coworkers when they 
studied the larger family of 1,3-dipolar cycloaddition reactions.
46
 However, thermal reactions of 
alkynes and azides have exceedingly low reaction rates due to high activation barriers, and also 
result in a mixture of regioisomers (Scheme 1.1A). The discovery of CuAAC in 2002 
demonstrated that Cu(I) catalyst rapidly increased the reaction rate of alkynes and azides even at 
room temperature (Scheme 1.1B).
46
 Following the breakthrough discovery of CuAAC, the first 







Scheme 1.1. General precursors, products, and reaction conditions for thermal cycloaddition of azides and alkynes (A) and 
CuAAC (B). Thermal cycloaddition reactions result in a mixture of regioisomers while CuAAC yields only 1,4-disubstituted 
regioisomers. Adapted from Hein et al.46 with permission of The Royal Society of Chemistry. 
 
Ultimately, “click chemistry”, CuAAC in particular, provided a bioorthogonal method to 
conjugate BMs and BFCs, and reduced the number of protection/de-protection steps required for 
radiotracer synthesis.
48
 Also, “click” reactions are commonly performed in mild, non-toxic, 
aqueous conditions that are amenable for the conjugation of biomolecules.
49
 More specifically 
for radiotracers, the resulting triazole ring from CuAAC conjugation reactions is highly resilient 
to degradation in vivo and displays tumor uptake comparable to analogous tracers using 
traditional prosthetic groups.
48, 50
 Despite the advantages of CuAAC for bioconjugation, 
challenges exist regarding the Cu(I) catalyst. Two key limitations of the CuAAC “click” reaction 




A convenient method to potentially avoid the aforementioned complications is to immobilize 
the Cu(I) catalyst on a solid support. Ligands have been used to not only stabilize the Cu(I) state, 







, and a number of other supports
56
 for CuAAC “click” reactions. Immobilized 
Cu(I) catalyst systems have the potential to minimize purification times
56
 and obviate the need 
for sodium ascorbate, commonly added to maintain Cu in the +1 oxidation state, which can 
10 
 





CuAAC addresses challenges related to the conjugation of BFCs and BMs, but progress in 
synthesis equipment is required to improve handling of precursors and products during synthesis 
of PET radiotracers. A few of the key challenges of current PET radiotracer synthesis are (1) the 
bulky size of current equipment that requires a commensurately large amount of radiation 
shielding, (2) excessive consumption of reagents, and (3) radiolysis, which is the cleavage of 
chemical bonds by ionizing radiation from free or incorporated radioisotopes that can reduce 
radiotracer yield. Regardless of what new technology is developed for PET radiotracer synthesis, 
the equipment must be able to synthesize radiotracers in a quick, robust, and repeatable manner 
with the potential for automation to improve worker safety.
40
 
Microfluidic devices, comprised of enclosed channels and features ~10s to 100s of 
micrometers tall/wide have the potential to address these challenges. The first microfluidic 
device, a miniaturized gas chromatography system, was created in the 1970s
58
, and many of the 
first microfluidic systems were microanalytical methods including capillary electrophoresis.
59, 60
 
The micro-total analysis system (μ-TAS) or “lab-on-a-chip” concept was introduced in 1990 by 
Manz et al.
61
; the concepts of which are now used in applications such as analysis and synthesis 
in fields ranging from chemistry to biology
62
. Eventually microfluidic platforms were used for 
radiotracer production with the first example occurring in 2004
63






 The use of microfluidics for PET radiotracer synthesis continued to grow after the 
initial example in 2004 and eventually a set-up was built in 2013 to produce radiotracers for use 





Microfluidics has the potential to address many challenges in radiotracer production including 
reducing reagent consumption and footprint to minimize costs.
66
 The small dimensions also 
enable precise control of reaction conditions including temperature and mass transfer, and 
microfluidic systems have the potential for automation. Furthermore, microfluidic designs can be 
adjusted to minimize radiolytic effects to improve radiotracer yields.
67
 Numerous radiotracers 
have been produced using microfluidic set-ups as outlined by Pascali et al.
40
 However, most 
microfluidic systems focus on the production of 
18
F-based radiotracers with little previous work 
on radiometal-based tracers. As discussed previously, radiometal-based PET tracers have 
advantages over traditional non-metal radiotracers including facile radioisotope incorporation 
and purification. These radiometal tracers could also benefit from the advantages provided by 
microfluidic systems. 
Combining CuAAC and microfluidics 
As depicted in Figure 1.1 the development of radiopharmaceuticals, “click chemistry”, and 
microfluidics have all just recently started to mature to a point enabling combination of these 
fields. The initial “lab-on-a-chip” concept wasn’t introduced until 1990
61
 and chip fabrication 
techniques were still in their infancy. CuAAC wasn’t discovered until 2002
44, 45
 and the term 
“click chemistry”
43
 was coined just one year before. Also, despite the long history of nuclear 
medicine, PET radiotracers for clinical oncology didn’t take off until the 1990s and even then 
PET didn’t truly grow until after [
18
F]FDG procedures began being reimbursed in 1998 and the 
FDA began to significantly change regulation for PET radiopharmaceuticals in 1997. Therefore, 
the combination of these three technologies didn’t begin until the mid-2000s. The work 
described in this dissertation describes how all three technologies (“click chemistry”, 
12 
 
microfluidics, and radiotracers) were combined by utilizing microfluidics and CuAAC to 
synthesize BM-BFC conjugates useful as PET radiotracers. 
1.4 Improving platforms for nanoparticle synthesis 
In addition to my work developing microfluidic platforms to improve PET radiotracer 
synthesis I also worked on developing a millifluidic mixer for use in nanoparticle (NP) synthesis 
in collaboration with Dr. Vivek Kumar, formerly a member of the Kenis lab. Nanoparticles 
possess unique optical, magnetic, and chemical properties that provide distinctive advantages 
over small molecule based imaging agents including (1) facile incorporation of multiple imaging 
modalities, (2) potential for higher signal-to-background ratios, and (3) localization at tumor sites 
via the enhanced permeability and retention effect due to “leaky” tumor blood vessels.
68, 69
 A 





, and Fe3O4 magnetic NPs
73
. However, most functionalized NPs are 
synthesized using low-yield synthetic strategies not amenable for scale up. Lohse et al. addressed 
this issue by creating a simple millifluidic reactor to produce AuNPs in a high throughput 
fashion, but specifically mentioned the current design was a “version 1.0” model and one 
potential improvement would be to incorporate new mixer designs.
74
 
Rapid mixing is critical for NP synthesis because poor mixing contributes to high 
polydispersity and poor batch-to-batch reproducibility.
75
 However, fast mixing at the micro- and 
millifluidic level can be challenging because flows are typically laminar due to the small channel 
dimensions and low velocities. Both active and static mixers have been developed to quickly mix 
solutions on the microfluidic scale. Active mixers require an external energy source while 
passive mixers only require pressure head and structures in the mixer to improve mixing.
76
 
Passive mixers are typically more desirable because they are simpler to fabricate and easier to 
13 
 
interface with other fluidic components.
77
 Many different types of passive mixers have been 




, and 3-D serpentine channels
79
. 
One of the most prevalent microfluidic mixers is the staggered herringbone mixer (SHM), 
originally developed by Stroock et al.
80




Microfluidic passive mixers have been studied extensively over the past decades.
83, 84
, but few 
efforts have focused on millifluidic mixers.
85
 Millifluidic platforms, like microfluidic platforms, 
enable rapid mass and heat transfer
86
, but millifluidics enables higher throughput and simpler 
fabrication.
74, 86, 87
 Many micromixers utilize traditional soft lithography techniques that typically 
use polydimethylsiloxane (PDMS) replica molding.
77, 80, 81
 Not only is PDMS replica molding 
more difficult for devices with larger features due to fabrication challenges (e.g., photoresist 
delamination, loss of PDMS features), but PDMS soft lithography techniques are not amenable 
for mass production. Poly(methyl methacrylate) (PMMA) has many desirable traits including 
optical transparency, low cost, and multiple methods for patterning features and bonding.
88
 
Additionally, previous work fabricated a groove based micromixer in PMMA (300 μm wide, 100 
μm deep including grooves) supporting the feasibility of using PMMA as an alternative material 
to create mixers.
89
 PMMA and other thermoplastics also have the potential for mass fabrication 
through injection molding or hot embossing unlike PDMS. 
Developing an improved millifluidic mixer for NP synthesis has the potential to improve 
throughput and reduce cost of fabrication while maintaining low polydispersity and high batch-
to-batch reproducibility. Additionally, micro- and millifluidic platforms are commercially 
available and reduce required expertise to fabricate and utilize these systems and improve the 
transition from academic research to industrial production.
90
 Continued development and 
14 
 
improvement of micro- and millifluidic platforms will enable both academic and industrial 
settings to take advantage of small-scale systems while reducing the expertise necessary for 
fabrication. 
1.5 Objectives 
The overall objective of my research is to improve micro- and millifluidic platforms for 
utilization in the medical imaging community, especially PET radiotracers. In my dissertation I 
will discuss two different small-scale platforms. The first platform is a “click chip” with an 
immobilized ligand with chelated Cu(I) to catalyze CuAAC reactions, and the second is a 
millifluidic static mixer that enables rapid mixing of reagents for applications including AuNP 
synthesis. Both platforms are useful to the medical imaging community but many fields utilize 
CuAAC or require rapid mixing including pharmaceutical synthesis, biological assays, and 
nanoparticle production. 
This dissertation is separated into five chapters, including this chapter. In Chapter 2 I discuss 
the design, fabrication, and initial testing of the “click chip”. Chapter 3 provides details on how 
the “click chip” design was improved to accommodate BM and BFC conjugation reactions. 
Furthermore, Chapter 3 discusses the validation of the improved “click chip” by testing three 
different BM and BFC conjugation reactions on the “click chip”. Chapter 4 switches gears from 
BM and BFC conjugation reactions to talk about the design, fabrication, and validation of a 
millifluidic SHM for AuNP synthesis. Finally, Chapter 5 summarizes the main conclusions of 
the dissertation and outlines future directions. 
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Development of a “click chip” with immobilized Cu(I) 
catalyst* 
2.1 Introduction 
The use of biomolecules such as peptides or antibodies as the targeting moiety for imaging 
agents has benefited from the development of “click chemistry” based reactions. A major benefit 
of “click” reactions is the reduction in the number of protection/de-protection steps due to the 
bioorthogonal nature of these reactions, the functional groups of neither the reactants nor the 
product interact with the functionalized biomolecule
1
, and only complementary functional 
groups form bonds. An additional advantage is that most “click” reactions are compatible with 
mild, non-toxic, aqueous conditions, a necessary feature for reactions involving many 
biomolecules. A review on the application of “click chemistry” and bioorthogonal reactions for 
labeling biological molecules was published by Best in 2009.
2
One of the most common “click” reactions is the Cu(I) catalyzed Huisgen 1,3-dipolar 
cycloaddition of an azide and alkyne.
3
 The Cu(I) state is thermodynamically unstable under 
normal oxidative conditions, but can be protected by complexation with the tetradentate ligand 
tris-(benzyltriazolylmethyl)amine (TBTA) from oxidation and disproportion.
4, 5
 For in vivo use, 
imaging agents prepared through “click chemistry” utilizing Cu(I) catalysis requires purification 
in order to remove the toxic copper salts and any associated ligands from the desired product. An 
additional consideration is the reducing agents required to maintain the Cu(I) oxidation state may 





Microfluidic devices, comprising enclosed micro-channels (normally 10-500 μm wide or tall), 
mixing units, heaters, pumping systems, are able to control and process chemical or biological 
reactions in a continuous flow manner or batch mode.
7-11
 Microreactor synthesis offers: (1) 
manipulation of small volumes, which mitigates issues associated with diluting reagents, (2) 
efficient mixing to prevent mass transfer limitations, and (3) exceptional control of reaction 
conditions, such as reagent concentrations and temperature, that enable reliable and reproducible 
reaction yields. These characteristics of microreactors for chemical processing and synthesis are 
attractive for in situ “click chemistry”, and have been successfully demonstrated in integrated 
microfluidics platforms for parallel or large-scale screening by Tseng et al.
10, 12
 
The previously mentioned undesirable requirements of the Cu(I) catalyzed “click” reaction 
(need for purification and side reactions of reductants) could be eliminated by the immobilization 
of an oxidatively robust Cu(I) complex. The catalytic copper center can be reduced to the active 
Cu(I) in the absence of sensitive biological molecules, and the catalyst can then be easily 
separated from the products. Many previous Cu(I) immobilization schemes utilize nitrogen or 







, and other solid supports
17
. One of the more promising 
immobilized catalyst systems, now commercially available through Sigma-Aldrich, was 
developed by Chan et al., and consisted of TBTA bound to TentaGel resin.
14
 Cu(I) bound to the 
TBTA functionalized TentaGel displayed high activity with minimal leaching. Solid supports, 
including TentaGel, can be adapted for use in microreactors by fabricating packed-bed 
microreactors and directly injecting the suitable resin into the microreactor. These reactors, 
however, suffer from issues inherent with packed bed systems, e.g., high pressure drops, 
channeling, and changes in resin swelling with different solvents. 
22 
 
An alternative approach is to immobilize the Cu(I) catalyst onto the microfluidic device itself. 
Sui et al. developed a facile method to functionalize intact polydimethylsiloxane (PDMS) 
devices using an acidic hydrogen peroxide solution and silanes.
18
 This method, or similar 









 onto PDMS surfaces. However, these functionalized PDMS features are primarily 
used for biological assays or to prevent analyte loss/microchannel fouling. A similar 
immobilization procedure was adopted here to immobilize a TBTA derivative to PDMS-glass 
microreactors to enable chelation and stabilization of Cu(I) in the +1 oxidation. These PDMS-
glass microreactors with immobilized Cu(I) are also called “click chips”. From an application 
perspective, the research reported here is unique because intact microreactors were 
functionalized with a chelated metal catalyst for synthetic applications. To the best of my 
knowledge there is only one report of immobilizing a metal catalyst to the surfaces of a PDMS-
based microreactor, this involved nanoparticles rather than a metal-chelate complex.
23
 
A key component of this research was to develop and evaluate a novel TBTA derivative with 
improved water solubility, capable of attachment to a silane functionalized microreactor. The 
immobilization process was characterized by both X-ray photoelectron spectroscopy (XPS) and 
radiotracer studies. The microreactor was validated by testing “click” reactions involving azides 
and alkynes, and the “click chip” demonstrated improved reaction yields compared to 
conventional techniques. To the best of my knowledge, this represents the first report of a 
microreactor incorporating an immobilized Cu(I) catalyst useful for bioconjugation, and where 




2.2 Results and discussion 
Microreactor design 
The microreactor was fabricated out of PDMS and glass for the following two reasons: (1) 
availability of simple, well-established methods for fabrication based on soft lithography, and (2) 
accessibility of multiple strategies for surface functionalization via creation of reactive silanol 
groups followed by silane attachment. Sui, et al.’s previous work in particular provided a facile 
method to form reactive silanol groups in intact PDMS devices for subsequent silanization.
18
 
Deep reactive ion etching (DRIE) was found to produce more robust silicon masters than 
traditional SU-8 based masters since the DRIE fabricated masters contained a fluorocarbon layer 
that provided easier liftoff of the PDMS imprints. Scanning electron microscope (SEM) was used 
to analyze masters and PDMS imprints. The resulting PDMS imprints from DRIE fabricated 
masters displayed no loss of posts after multiple uses of the masters (Figure 2.1A) while PDMS 
imprints made from traditional SU-8 based masters exhibited missing posts with continued use 
of the masters (Figure 2.1B). When fabricating microreactors with dense features, it may be 
more efficient to etch silicon using DRIE and then apply a fluorocarbon layer rather than attempt 
to optimize a process based on traditional SU-8 soft lithography techniques. 
 
Figure 2.1. SEM images of a tank with PDMS posts from PDMS imprints using masters created by DRIE (A) and standard SU-8 




The microreactor design (Figure 2.2) included two key features: (1) posts and (2) reservoirs. 
The posts were placed in a hexagonal packing scheme (Figure 2.1) with a 200 μm center-to-
center distance from one post to any adjacent post. The posts served primarily to reduce reagent 
diffusion distances to a catalytic site while also slightly increasing the available surface area for 
immobilization of the catalyst (~30% increase compared to a device without posts). The 





where tD is the approximate diffusion time of reagents, l is the characteristic length, and D is the 
diffusion coefficient. With 100 μm diameter PDMS posts spaced 100 μm apart (edge of one post 
to edge of adjacent post) the approximate diffusion time of reagents to an active catalytic site is 










), significantly shorter 
than the typical overall incubation time (>10 min). Using Equation 2.1, diffusion times for a 
device without posts would be roughly 40 seconds with respect to the microreactor bottom and 
top, but it would take hours to diffuse to the sides of a reservoir. The microreactor contained five 
reservoirs with an average height of 125.99 ± 1.61 μm (n = 13) to provide an adequate sample 
volume (~46 μL) for analysis. The height and/or number of tanks can be easily adjusted to 
provide the desired sample volume with minimal pressure drop compared to scaling up channel-
based microreactors. Additionally, if the number of reservoirs changed, the surface area-to-
volume ratio is maintained, providing the possibility of adjusting sample volume with minimal 




Figure 2.2. CAD image of the “click chip” design used for all experiments in Chapter 2. The chip has five reservoirs to provide 
adequate sample volume for analysis, and each reservoir is filled with 100 μm diameter posts to reduce diffusion time of reagents 
to an active catalyst site. The scale bar is 5 mm. 
 
Ligand immobilization and characterization 
The TBTA-Cu(I) complex has been shown to be an efficient catalyst for “click” reactions.
5, 14
 
The Cu(I) state is unstable under normal oxidative conditions, but can be stabilized by 
complexation with the tetradentate TBTA ligand.
4, 5
 The TBTA ligand has been immobilized on 




, to afford an active Cu(I) 
catalyst source for “click” reactions. One major challenge of the original TBTA developed by 
Chan et al. from the standpoint of biomolecule compatibility is the limited water solubility of 
TBTA. To address this issue a series of TBTA derivatives (data not shown) were developed and 
a water-soluble TBTA derivative (ligand 2) was determined to be the optimal choice for Cu(I) 
immobilization. The synthesis of ligand 2 started from a “mono-click” reaction of 
tripropargylamine and 11-azido-3,6,9-trioxaundecan-1-amine in the presence of the Cu(I) 
catalyst tetrakis(acetonitrile)copper(I) hexafluorophosphate to afford mono-PEG linker 
substituted intermediate 1 in 29.7% yield. A second “click” reaction between intermediate 1 and 





Scheme 2.1. Synthesis of a water-soluble TBTA derivative, ligand 2. 
 
 
Scheme 2.2. Immobilization of ligand 2 on chip surfaces. 
 
Ligand 2 was successfully immobilized onto the surface of microreactors (Scheme 2.2) by 
first activating the surface with an acidified hydrogen peroxide solution, then covalently bonding 
the silane 3-(trimethoxylsilyl)propyl acrylate (TMSPA) to the activated surface groups, followed 
by attaching ligand 2 to the TMSPA. Finally, an aqueous Cu(I) solution was injected to form the 
Cu(I)-ligand 2 complex (see materials and methods section for more details). XPS was utilized to 
validate each step of the immobilization process on glass and PDMS substrates. The four 
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individual steps tested using XPS were: (1) non-functionalized substrate (control), (2) substrate + 
TMSPA, (3) substrate + TMSPA + ligand 2, and (4) substrate + TMSPA + ligand 2 + Cu(I). 
 
Figure 2.3. C1s narrow scan spectra of glass (A) and PDMS (B) and survey spectra of glass (C) and PDMS (D) at each stage of 
functionalization: non-functionalized substrate (black); substrate + TMSPA (red); substrate + TMSPA + ligand 2 (blue); substrate 
+ TMSPA + ligand 2 + Cu(I) (green). 
 
Two types of XPS spectra, survey spectra covering a wide range of binding energies to 
determine what elements were present and narrow scan spectra to analyze the various states of 
specific elements, were performed and analyzed. C1s narrow scan spectra of glass (Figure 2.3A) 
and PDMS (Figure 2.3B) substrates after covalent bonding of TMSPA to activated surface 
groups indicated TMSPA was successfully bonded based on (1) a new characteristic peak (red 
lines vs. black lines) at ~289 eV that corresponds well to the O-C=O carbon found in acrylate 
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groups and (2) a new or relatively larger peak (red lines vs. black lines) at ~286 eV indicative of 
C-O bonds. The C1s narrow scan spectra also demonstrated successful bonding of ligand 2 to 
TMSPA for both glass and PDMS substrates (Figure 2.3A and B) because of the increase in size 
of the ~286 eV peak (C-O bond) relative to other peaks in the C1s spectra (blue or green lines vs. 
red or black lines) that indicates the presence of ethylene glycol moieties of polyethylene glycol 
(PEG) chains in ligand 2. Survey scan spectra of glass (Figure 2.3C) and PDMS (Figure 2.3D) 
substrates after attaching ligand 2 (blue and green lines) also supported the conclusion that ligand 
2 was successfully immobilized based on a substantial N1s peak at ~400 eV that is best 
explained by the triazole moieties in ligand 2. 
 
Figure 2.4. C1s narrow scan spectra of glass (A) and PDMS (B) after ligand 2 was incubated on both substrates without 
activating the surfaces with an acidified hydrogen peroxide solution and covalently bonding TMSPA to the surfaces. The black 
lines (non-functionalized substrate) and blue lines (substrate + TMSPA + ligand 2) are the same used in Figure 2.3 and are 
present for comparison purposes. 
 
A negative control study was also performed to demonstrate the silanization process was 
essential for ligand 2 immobilization onto glass (Figure 2.4A) and PDMS (Figure 2.4B) 
surfaces. For this experiment the first two steps of the immobilization process (surface activation 
and TMSPA attachment) were skipped, and ligand 2 was directly incubated on both glass and 
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PDMS. The near identical profiles of the black lines (non-functionalized substrate) relative to the 
red lines (substrate + ligand 2 (no TMSPA)) in Figure 2.4 indicate ligand 2 was not successfully 
bonded to either the glass or PDMS surface and was washed away during the rinse step. 
Therefore, the TMSPA is critical for permanent attachment of ligand 2 to both glass and PDMS 
surfaces. 
Finally, XPS also confirmed the presence of copper and provided information on the oxidative 
state of the copper chelated to ligand 2. The presence of Cu2p peaks in the survey spectra (green 
lines) of glass (Figure 2.3C) and PDMS (Figure 2.3D) demonstrate the presence of Cu on both 
samples. Furthermore, the presence of a symmetrical Cu2p3/2 peak and the lack of shake-up 
peaks in the Cu2p narrow scan spectra of both glass (Figure 2.5A) and PDMS (Figure 2.5B) 




Figure 2.5. Cu2p narrow scan spectra of glass (A) and PDMS (B) after Cu(I) chelation to immobilized ligand 2. 
 
Microreactors with ligand 2 attached had a colorless appearance. However, after 
immobilization of Cu(I), the “click chips" displayed a visibly yellow appearance. The amount of 
ligand 2 immobilized on the chip was quantified via radiotracer methods. Using a carrier-added 
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Cu(I) solution that consists of a known concentration of cold copper with a trace amount of 
radioactive Cu-64, the amount of bound copper was determined by measuring the radioactivity 
of the chips. This value also roughly estimates the amount of ligand 2 immobilized onto the chip 
surface assuming the active catalyst was a 1 : 1 complex of Cu(I) and ligand 2 and little non-
specific binding. Microreactors with five tanks filled with posts and functionalized with ligand 2 
had 1136 ± 272 nmol of immobilized Cu(I) (n = 3). After accounting for the internal 
microreactor surface area, the immobilized Cu(I) density was 81 ± 20 nmol cm
-2
. 
Because a previous study demonstrated that copper could adsorb onto the surface of PDMS-
based chips
26
, a control study was performed to measure the non-specific binding of Cu(I) onto 
PDMS-glass microreactor surfaces. The various chemical modifications involved with the 
immobilization of ligand 2 makes it difficult to choose an ideal control model for the surface 
adsorption of copper. A plain chip without any functionalization was chosen as the control 
model, but results may have greater amounts of non-specifically bound Cu(I) than the actual 
“click chip” with immobilized ligand 2 because the TMSPA occupies potential Cu(I) binding 
sites on the glass and PDMS surfaces. Control chips with no surface treatment were treated with 
a radioactive Cu(I) buffer solution using the same process used for “click chips”. Low amounts 
of Cu-64 (36-48 μCi, decay corrected) were observed on the chip indicating low amounts of non-
specific binding of copper onto the PDMS and glass surfaces (380 ± 55 nmol). After treatment 
with an ethylenediaminetetraacetic acid (EDTA) solution (0.05 M, pH 6), only minimal amounts 
of copper (7-10 μCi, decay corrected) remained on the chip, which corresponded to a copper 






Figure 2.6. Carrier-added Cu(I) solution was injected into chips with immobilized ligand 2 (functionalized chip) and chips with 
no surface modifications (plain chip). After rinsing the devices the activity was quantified and used to calculate the amount of 
copper present. Data is presented as the mean ± standard deviation (n = 3). 
 
“Click” reactions on chip 
To validate the “click chip”, reactions between Flu568-azide and propargylamine or Flu568-
acetylene and an azide derivative of the small peptide, cyclo[Arg-Gly-Asp-D-Phe-Lys] 
(cRGDfK-azide), were tested on chip (Scheme 2.3). Flu568-azide/acetylene are derivatives of a 
common dye, chosen because the compounds are easily detected by the UV-Vis detectors on 
high-performance liquid chromatography (HPLC) set-ups. Propargylamine is a widely used 
alkyne to test “click” reactions and cRGDfK-azide is a small peptide, easily synthesized, that is 




Scheme 2.3. Reactions between Flu568-azide and propargylamine (A) and Flu568-acetylene and cRGDfK-azide (B) were used 
to validate the “click chip”. 
 
Initial tests were performed with Flu568-azide and propargylamine. Reaction yield increased 
with prolonged incubation period on a “click chip”. The yield after a 15 min incubation time (55 
± 9%) increased to 76 ± 8% after incubating for 30 min, and increased to 83 ± 4% after 50 min in 
a “click chip” (Figure 2.7A). The same reaction (Flu568-azide and propargylamine) was tested 
on a different “click chip” and similar yields (e.g., 52 ± 7% for 15 min reaction) were achieved, 
indicating the functionalization process is reproducible. 
The same Flu568-azide and propargylamine reaction was also testing using a conventional set-
up (reaction vials on a ThermoMixer) using the same reaction conditions (i.e., reactant 
concentration, volume, time, and temperature). The yield was only 12 ± 2% with 60 mol% of 
Cu(I)-TBTA catalyst after incubating for 15 min (Figure 2.7B). The yield did increase to 81 ± 
3% in the presence of a large excess of catalyst (~2000 mol%) (Figure 2.7B). However, using 
this conventional approach with an excess of catalyst would require a purification step to remove 
the catalyst that is not required after reactions on the “click chip” because Cu(I) is chelated to the 
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immobilized ligand 2. Additionally, the results from the “click” reaction using the conventional 
set-up clearly indicate the “click chip” surface is immobilized with sufficient active catalyst to 
promote the tested “click” reaction in a short period of time (~10s min). 
 
Figure 2.7. “Click” reaction of Flu568-azide and propargylamine at 37 °C using a “click chip” after an incubation time of 15, 30, 
or 50 min (A) and using a conventional set-up after an incubation time of 15 min with different concentrations of catalyst (B). 
Data is presented as the mean ± standard deviation (n = 3-4). 
 
To confirm the Cu(I)-ligand 2 complex was the active catalyst, the “click” reaction between  
Flu568-azide and propargylamine was performed on a plain chip without immobilized ligand 2. 
A Cu(I)-ascorbate solution was pumped through the chip, then the chip was washed with DI 
water. When reagents were incubated on the plain chip for 15 min the nonspecifically bound 
Cu(I) catalyzed the reaction, but with a lower yield (16 ± 5%) compared to the “click chip” (55 ± 
9%). Even when the reaction was repeated on the same control chip with a 30 min incubation 
time, the reaction yield (7 ± 2%) was still much lower than reactions on the “click chip” (76 ± 
8%) (Figure 2.8). These results strongly indicate the immobilized Cu(I)-ligand 2 complex is the 




Figure 2.8. “Click” reaction between Flu568-azide and propargylamine in a functionalized chip (“click chip”) or a chip without 
immobilized ligand 2 incubated for 15 min (red bars) or 30 min (blue bars). Data is presented as the mean ± standard deviation (n 
= 4). 
 
The functionalization of “click chips” remained effective for at least one month as long as the 
Cu(I) catalyst was regenerated periodically. Flu568-azide and propargylamine “click” reactions 
were performed on the same “click chip” on different days to study the shelf-life of the ligand 2 
immobilized chip. Reaction yields 0, 1, 3, 7, and 10 days after the initial addition of Cu(I) 
solution into the chip were similar. Additionally, the reaction yield 10 days after the initial 
addition of Cu(I) solution (48 ± 5%) was similar to yield for the initial reaction on day 0 (55 ± 
9%), even after three additional injections of Cu(I) into the “click chip”. Furthermore, the yield 
of Flu568-azide and propargylamine “click” reactions after 30 min of incubation time on a “click 
chip” (76 ± 8%) could be repeated ~20 days later with near identical yields (77 ± 6%) on the 
same chip. The reaction yield remained above 80% (50 min incubation time) after one month of 
using the same “click chip”. After five regenerations of the Cu(I)-ligand 2 catalyst, however, the 
reaction yield decreased, and the tank surface became discolored in some spots which indicated 




Figure 2.9. Reaction between Flu568-azide and propargylamine on the same “click chip” for 15 min at 37 °C over several days. 
Cu(I) was regenerated periodically prior to the first reaction on some days (red bars) by injecting more Cu(I) solution into the 
“click chip”. Blue bars represent days where Cu(I) was not re-injected into “click chip” and the chip was used as is. Data is 
presented as the mean ± standard deviation (n = 3-4). 
 
To validate the application of the reactor for use with biomolecules, the “click” reaction 
between an azide containing peptide, cRGDfK-azide
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 and Flu568-acetylene was studied. This 
reaction was performed five times on a “click chip” (30 min incubation time) with only small 
deviations in product yield (75 ± 3%) (Figure 2.10). The reported reaction yield was based on 
the conjugated peptide and not on the loss of Flu568-acetylene because some Flu568-acetylene 
was converted into an uncharacterized byproduct (HPLC elution time of 13.4 min). The 
byproduct likely arose from a reaction between the Flu568-acetylene and the Cu(I) catalyst. The 
same byproduct was also observed in the conventional reaction, when Flu568-acetylene and 
cRGDfK-azide were mixed with Cu(I)-TBTA at 37 °C. The conventional reaction of cRGDfK-
azide and Flu568-acetylene with 60 mol% catalyst afforded a product yield of 54 ± 5%, which 
was lower than the same reaction on a “click chip” (75 ± 3% ) (Figure 2.10). These results 
confirm a biomolecule (RGD peptide) was compatible with the catalyst-immobilized chip, and a 




Figure 2.10. “Click” reaction between Flu568-acetylene and cRGDfK-azide in a “click chip” with immobilized ligand 2 and a 
conventional reactor. Reactions were incubated for 30 min at 37 °C. Data is presented as the mean ± standard deviation (n = 3-5). 
 
2.3 Materials and methods 
All solvents and chemical reagents were purchased from Sigma-Aldrich or Fisher Scientific 
unless specified. All chemicals were used without further purification. Flu568-azide and Flu568-
acetylene were purchased from Click Chemistry Tools. Deionized (DI) water was produced in-
house using either the water purification system maintained at the Micro-Nano-Mechanical 
Systems Cleanroom at the University of Illinois (all wafer fabrication steps), or a Barnstead e-
Pure filtration system (UIUC) or a Millipore Milli-Q water purification system (Wash U) for all 
other methods. 
64
CuCl2 was produced at Washington University in St. Louis School of Medicine, 
and obtained in a 0.1 M HCl solution. Silicon wafers were purchased from University Wafer. 
AP-8000 adhesion promoter and SPR220-7.0 were purchased from MicroChem, and used for 
fabricating silicon master templates. Sylgard 184 PDMS was purchased from Dow Corning. 
Glass microscope slides were purchased from Fisher Scientific, and used to manufacture PDMS 
reactors. Microbore polytetrafluoroethylene (PTFE) tubing (0.012" ID, 0.030" OD) was 
purchased from Cole-Parmer. Silica TLC plates and C18 TLC silica plates were purchased from 
Sorbent Technologies. 
1
H NMR and 
13
C NMR spectrometry were performed on an I400 Varian 
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Inova NMR instrument (400 MHz for 
1
H NMR and 100.5 MHz for 
13
C NMR). MALDI-TOF 
mass spectrometry was performed on a Voyager-DE STR BioSpectrometry Workstation. High 
resolution electrospray ionization mass spectrometry was conducted on a Thermo Scientific LTQ 
Orbitrap Velos mass spectrometer with Xcalibur operating system. Three microliter flow 
modular pump components (syringe pump, a pump driver circuit, and a power supply) were 
obtained from Harvard Apparatus. A Kapton-insulated thin film heater (2” x 2”), Omega CN740 
temperature controller and an Omega SA 1-RTD probe were obtained from Omega Engineering. 
The ThermoMixer C was purchased from Eppendorf North America. Microliter syringes were 
obtained from Hamilton Co. The Capintec CRC-712M radioisotope dose calibrator was 
purchased from Capintec Inc., and used for the measurement of radioactivity. X-ray 
photoelectron spectroscopy was performed on a Kratos Axis Ultra. Scanning electron 
microscope imaging was performed on a Hitachi S-4700 SEM with an acceleration voltage of 2 
kV. Surface profilometer measurements were taken on an Alpha Step IQ profilometer. Analytical 
reverse phase HPLC was performed on a Hewlett Packard 1050 series (Model 35900E), and 
analyzed with Chem Station IC software. The HPLC analytical column was an Econosil C18 
reverse phase column (10 µm, 250 mm) from Alltech Associates, Inc. The flow rate was 1 mL 
min
-1
 for analytical HPLC and 2.5 mL min
-1
 for semi-preparative HPLC, with the mobile phase 
of solvent A (0.1% TFA in water) and solvent B (0.1% TFA in acetonitrile). The UV detector 
was set at 576 nm. The gradient analytical HPLC method started at 25% B (0-5 min) and rose to 
60% B (10-16 min), and returned to 25% B (16.5-20 min). 
PDMS-glass chip fabrication 
Lithography. Silicon wafers were rinsed, dried with filtered nitrogen, heated on a hot plate, 
and then cooled with filtered nitrogen. An adhesion promoter (AP-8000) was dispensed onto the 
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wafers and spin-coated in three consecutive steps: 500 rpm for 2 s, 1500 rpm for 2 s, and 3000 
rpm for 30 s. Then SPR220-7.0 (5 mL) was dispensed onto the wafers and spin-coated in two 
consecutive steps: 500 rpm for 10 s and 2000 rpm for 30 s. The photoresist was soft baked on a 
hotplate for 30 s at 65 °C, 110 °C for 3 min, then 65 °C for 30 s, and finally cooled to room 
temperature for 3 min. The photoresist was exposed to UV light with an intensity of ~14 mW 
cm
-2
 through a transparency mask (FineLine Imaging, Colorado Springs, Colorado) and a quartz 
block for 15 s followed by a 1 min waiting period. The exposure process was repeated twice for 
a total exposure time of 45 s. Exposed photoresist was removed by vigorously swirling wafers in 
a solution of DI water/AZ400K developer for 1 to 3 min. Wafers were rinsed with DI water and 
dried with filtered nitrogen. The photoresist was then hard baked on a hot plate for either (1) 30 s 
at 65 °C, 3 min at 110 °C, and 30 s at 65 °C or (2) 3 min at 80 °C, to make the photoresist more 
resilient to etching. 
Etching. Wafers were briefly cleaned with oxygen plasma, and etched using a Bosch process 
with a PlasmaTherm ICP-DRIE. After etching, the wafers were swirled for 10 min in 1165 PR 
stripper, then rinsed with acetone and isopropanol, and finally dried with filtered nitrogen. A 
flurocarbon passivation layer was deposited to prevent PDMS from adhering to the silicon. 
Profilometer height measurement. After etching the silicon wafers and depositing a 
fluorocarbon passivation layer the etch heights were measured with a profilometer on the top of a 
vibration free table. Measurements were made over 13 different sections of the masters. Heights 
are expressed as the average ± standard deviation. 
PDMS attachment to glass. Sylgard 184 reagent was combined in a 10 : 1 mass ratio 
(base/curing agent), mixed thoroughly, and degassed in a vacuum desiccator for ~20 min. The 
PDMS was poured into a petri dish containing the etched master, and cured in an oven at 65 °C 
39 
 
for ~2 h. The PDMS was peeled from the master, and the holes for inlets and outlets were 
punched using a 19 gauge hypodermic tubing with beveled edges. Glass slides were scrubbed 
with a Texwipe soaked in an aqueous Alconox solution, and rinsed with DI water, then dried 
with filtered nitrogen. The PDMS and glass were then exposed to oxygen plasma generated by 
an Atomflo atmospheric plasma system (Surfx Technologies) with power set at 100 W, helium 
flow at 15.0 L min
-1
 and oxygen flow at 0.30 L min
-1
. PDMS and glass were slowly passed ~4 
times under the plasma, while the oxygen plasma exited a nozzle which was held ~2 cm above 
the surfaces. The PDMS was immediately sealed to the glass and incubated in an oven at 65 °C 




Figure 2.11. Schematic of the fabrication steps for making the PDMS-glass microreactors. 
 
Synthesis of water-soluble TBTA ligand (ligand 2) 
8-Azido-3,6-dioxaoctanol. 8-chloro-3,6-dioxaoctanol (5 g, 28.5 mmol) was dissolved in DI 
water (25 mL). Sodium azide (2.4 g, 36.9 mmol) was added to the reaction solution in three 
portions with caution. The reaction solution was refluxed at 105 °C for 48 h. After the reaction 
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solution cooled to room temperature, the solvent was removed under vacuum. The residue was 
washed with acetone (150 mL) to remove any solid salt. The liquid layer was dried over 
anhydrous sodium sulfate, and then concentrated. The product was further dried under vacuum 
overnight to afford a viscous yellow liquid (5 g, 96%). 
1
H NMR (400 MHz, CDCl3): δ 3.67-3.62 
(m, 8H), 3.55 (t, J = 4.4 Hz, 2H), 3.34 (t, J = 4.4 Hz, 2H), 2.77 (br, 1H). 
13
C NMR (100.5 MHz, 
CDCl3): δ 72.36, 70.41, 70.14, 69.82, 61.46, 50.41. 
Intermediate 1. Tripropargylamine (0.96 g, 7.34 mmol) and tetrakis(acetonitrile)copper(I) 
hexafluorophosphate (136.8 mg, 0.37 mmol) were dissolved in tetrahydrofuran (10 mL) in a 200 
mL round-bottom flask under a nitrogen atmosphere. 11-azido-3,6,9-trioxaundecan-1-amine (0.4 
g, 1.83 mmol) was dissolved in tetrahydrofuran (20 mL) and the solution was added to the 
reaction solution dropwise over 30 min at 40 °C. Then the reaction solution was refluxed at 66 
°C for 18 h. After the reaction, the solution was cooled to room temperature. The product was 
purified by chromatography on a silica column eluting with methanol/dichloromethane (5 : 95), 
and then triethylamine/methanol/dichloromethane (2 : 10 : 88). The product was obtained as a 
yellow viscous liquid (0.19 g, 29.7%). 
1
H NMR (400 MHz, CDCl3): δ 7.74 (s, 1H), 4.85 (br, 
2H), 4.54 (t, J = 5.0 Hz, 2H), 3.85 (t, J = 5.0 Hz, 2H), 3.79 (s, 2H), 3.67 (t, J = 4.8 Hz, 2H), 3.60-
3.54 (m, 8H), 3.41 (d, J = 2.4 Hz, 4H), 3.09-3.00 (m, 4H), 2.29 (t, J = 2.2 Hz, 2H). 
13
C NMR 
(100.5 MHz, CDCl3): δ 143.64, 124.25, 78.21, 73.67, 70.06, 70.01, 69.91, 69.79, 69.26, 66.38, 
50.00, 47.61, 45.70, 41.63. MALDI-TOF: calcd for C17H27N5O3 [M]
+
: 349.21; found: 349.26. 
HRMS (ESI): calcd for C17H28N5O3 [M + H]
+
: 350.2187; found: 350.2186. 
Water-soluble TBTA ligand 2. Intermediate 1 (0.19 g, 0.54 mmol), 8-azido-3,6-dioxaoctanol 
(0.23 g, 1.31 mmol) and tetrakis(acetonitrile)copper(I) hexafluorophosphate (81 mg, 0.22 mmol) 
were dissolved in tetrahydrofuran (5 mL) and refluxed at 66 °C under nitrogen flow. After 18 h, 
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the reaction solution was cooled to room temperature. The solution was mixed with 
QuadraPure
TM
 TU resin (0.3 g) in a 50 mL round-bottom flask for 3 h. The solution was filtered, 
and the crude product was concentrated and purified by chromatography on a silica column using 
a gradient elution solvent system (methanol/dichloromethane 5 : 95 to 
triethylamine/methanol/dichloromethane 2 : 20 : 78). The product was afforded as a yellow 
viscous liquid (0.12 g, 31.6%). 
1
H NMR (400 MHz, CDCl3): δ 8.06 (s, 2H), 8.04 (s, 1H), 4.60-
4.58 (m, 6H), 3.92-3.90 (m, 6H), 3.75 (s, 6H), 3.63-3.56 (m, 20H), 3.51-3.49 (m, 6H), 3.20-3.12 
(m, 2H). 
13
C NMR (100.5 MHz, CDCl3): δ 143.52, 124.86, 72.10, 69.87, 69.84, 69.67, 68.84, 
66.37, 60.63, 49.84, 47.50, 46.86, 46.22. MALDI-TOF: calcd for C29H53N11O9 [M]
+
: 699.40; 
found: 699.26. HRMS (ESI): calcd for C29H54N11O9 [M + H]
+
: 700.4100; found: 700.4099; calcd 
for C29H55N11O9 [M + 2H]
2+
: 350.7087; found: 350.7086. 
Procedures and evaluation for ligand 2 immobilization on chip 
Ligand immobilization. The PDMS-glass chip was activated with an acidified hydrogen 
peroxide solution (H2O2/HCl/H2O 1 : 1 : 5, 4 mL) with a flow rate of 50 µL min
-1
. Then the chip 
was washed with DI water (1 mL), and dried with air for 4 min. A neat solution of TMSPA was 
pumped into the activated microreactor at 50 µL min
-1 
for 20 min, then dried by injecting air. 
The silanized chip was annealed at 70 °C under vacuum for 2 h to cure the surface. Ligand 2 
(19.5 mg, 29.8 µmol) was dissolved in a 10 mmol% borax solution (1.5 mL),
28
 and the solution 
was sonicated for 20 min. The solution was pumped into the chip at a rate of 10 µL min
-1 
at 47 
°C for 150 min. The immobilized chip was washed with water and methanol (2 mL for each 
solvent), the chip was then dried with air flow for 10 min. 
XPS analysis. XPS experiments were performed using a monochromatic aluminum X-ray 
source (1486.6 eV). Pass energy was 160 eV for survey spectra and 40 eV for narrow scan 
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spectra. All spectra were collected at a photoelectron take-off angle of 90°. To account for 
sample charging a flood gun was utilized and the hydrocarbon C1s peak was referenced to 285.0 
eV. Analysis was performed utilizing CasaXPS version 2.3.16 software. Shirley background 
subtraction was used for all analyses. 
Substrates for XPS analysis were prepared in a similar fashion to “click chips”. Activated 
chips could not be used for XPS analysis primarily because (1) chips consisted of permanently 
bound PDMS to glass slides and this bond is difficult to break without ripping the PDMS, (2) 
because thick PDMS outgasses under vacuum and requires extensive time for the XPS set-up to 
achieve the appropriate vacuum for use, and (3) samples must be able to fit on the XPS stage. 
Due to the second issue, 10:1 PDMS for XPS analysis was prepared by spin-coating on clean 
silicon wafers, then cured in a 65 °C oven for 2 h. After cooling to room temperature the PDMS 
was covered with Scotch tape and the silicon wafer with PDMS was snapped in half after scoring 
with a diamond tipped scribe. Glass pieces for XPS analysis were cut to ~37 x 37 mm in size. 
The following process describes the general method used for the complete Cu(I) 
immobilization process of glass and PDMS substrates for XPS analysis. The process was stopped 
at different points for some substrates to analyze the surface after (1) attaching TMSPA, (2) 
bonding ligand 2 to the TMSPA, and (3) chelating Cu(I) to ligand 2. Individual pieces were first 
cleaned by soaking in a crystallizing dish with methanol while swirling the dish by hand to 
mimic injecting the solution into a “click chip”, all soaking steps where swirled in a similar 
fashion. Pieces were rinsed and soaked in DI water for 10 min, then dried with N2. PDMS and 
glass substrates were soaked in an acidic hydrogen peroxide solution (same concentration used 
for “click chip” functionalization). Pieces were rinsed with water, methanol, and then water 
again and dried with N2. The acidified hydrogen peroxide soak and rinsing process were repeated 
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two more times. Silicon isolators were attached to pieces (Grace Bio-Labs, 25 x 25 mm outside 
perimeter, 13 mm internal diameter cut out) to enable functionalization of a specific location to 
reduce the amount of ligand 2 used. Samples were then placed in a glove bag with TMSPA. The 
bag was filled with N2 to prevent cross-linking of the TMSPA due to water in the air. 200 μL of 
TMSPA was added inside the silicon isolator and incubated for 1 h at room temperature. 
Substrates were then rinsed and soaked in methanol for 4 min, then dried with N2 and placed in a 
65 °C oven for 2 h. Substrates were allowed to cool to room temperature, rinsed with methanol, 
rinsed with water and then soaked in water. 
To attach ligand 2 to the surface, a second silicon isolator was added on top of the first to 
prevent the ligand 2 and borax solution to come in contact with a glass cover during the 
incubation period. To that end a second silicon isolator was added on top of the first and 190 μL 
of ligand 2 (20 mM) and borax (100 mM) solution were added inside the silicon isolator, and a 
piece of glass slightly larger than the isolator was placed on top to seal the chamber. Glass 
microscope slides were placed on either side of the substrate and glass cover and clamped 
together using a binder clip. After incubating for 20 h at room temperature, the ligand 2 and 
borax solution was aspirated off then substrates were rinsed with water then methanol, soaked in 
methanol for 6 min then soaked in water for 6 min and dried with N2. A Cu(I) solution (5 mM 
CuSO4 and 100 mM sodium ascorbate) was prepared and 250 μL of Cu(I) solution was added to 
the silicon isolator and incubated for 30 min. The Cu(I) solution was aspirated off and the Cu(I) 
incubation step was repeated once more. Finally the substrates were rinsed with water, soaked in 
water for 5 min, and dried with N2. All substrates were trimmed to slightly larger than the 13 mm 
diameter hole from the silicon isolator using a diamond tipped scribe and breaking along the 
scored lines. This ensures all pieces will fit on the XPS stage. 
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Quantifying immobilization efficiency. Plastic syringes and Eppendorf tubes were washed with 
nitric acid (1 N) three times to remove any non-specifically bound metals. They were then 
washed with DI water followed by acetone, and dried with air. A Cu-64 stock solution was 
prepared in sodium acetate buffer (pH 5.5, 0.1 M). Carrier-added Cu(I) solution was prepared by 
adding a 100 mM sodium ascorbate solution to a 10 mM radioactive copper sulfate solution with 
specific activity of ~130 Ci mol
-1
. The radiolabeling process was performed at room temperature. 
The carrier-added radioactive Cu(I) solution (~500 µCi) was pumped into the chip at a rate of 20 
µL min
-1 
for 30 min, then the chip was cleaned with DI water thoroughly (4 mL), and dried under 
air flow. All PTFE tubing was removed, and the radioactivity of the chip was quantified (120-
190 µCi, decay corrected). The calculated amount of immobilized Cu(I) was 1136 ± 272 nmol, 
and the density of Cu(I) was 81 ± 20 nmol cm
-2
. 
Control study with nonspecific binding of Cu-64. A non-functionalized chip of the same design 
was cleaned with methanol and water separately at 50 µL min
-1 
for 10 min. Carrier-added Cu(I) 
solution was prepared by adding 100 mM sodium ascorbate solution to a 10 mM radioactive 
copper sulfate solution with a specific activity of ~110 Ci mol
-1
. The carrier-added radioactive 
Cu(I) solution (~500 µCi) was pumped into the chip at a rate of 20 µL min
-1 
for 30 min, then the 
chip was cleaned with DI water thoroughly (4 mL), and dried under air flow. All PTFE tubing 
was removed, and the radioactivity of the chip was quantified. The original tubing was then re-
inserted into the chip. To determine the amount of removable copper bound to the surface, an 
EDTA solution (pH 6, 0.05 M, 1 mL) was pumped into the chip at 30 µL min
-1
. Then all tubing 
was removed and the radioactivity of the chip was quantified (7-10 µCi, decay corrected). The 





General procedures for conventional and on chip “click” reactions 
On chip “click” reactions. 100 µM stock solutions of Flu568-azide and Flu568-acetylene were 
prepared in an ammonium acetate buffer (pH 6.8, 0.1 M) with 1% sodium dodecyl sulfate to 
increase the solubility. The solution was sonicated for 10 min. Propargylamine stock solution 
was prepared as 400 µM in an ammonium acetate buffer. The synthesis of cRGDfK-azide 
peptide was reported previously,
27 
and prepared as a 600 µM solution in an ammonium acetate 
buffer. The reaction solution consisted of equal volumes of two reagent stock solutions, and was 
pumped into chips from one inlet. The second inlet was connected to a syringe filled with 
ammonium acetate buffer. Prior to the first reaction and some subsequent reactions, chips with 
immobilized ligand 2 were activated by injecting a 5mM Cu(I) solution into the chips prepared 
from 10 mM copper sulfate and 200 mM sodium ascorbate solutions. After injecting Cu(I) into 
“click chips”, they were washed thoroughly with DI water (5 mL). Then the reagent solution was 
pumped into the chip at a flow rate of 25 µL min
-1
. The reactant flow was controlled by a 
microliter flow modular pump system. Reagent solutions were incubated on chip at 37 °C for 15, 
30, or 50 min. After the reaction, the product was eluted from the chip by flowing ammonium 
acetate buffer into the chip. The chip was further washed with buffer (500 µL) to remove any 
reaction residue. The reaction was repeated for 4-6 times under the same conditions. The active 
catalyst immobilized on the chip could be repeatedly regenerated with 5 mM Cu(I) solution as 
described previously. The products were analyzed by reverse-phase HPLC, and characterized by 
MALDI-TOF mass spectrometry. The “click” products of the reaction between Flu568-azide and 
propargylamine were determined by HPLC with yields of 54 ± 9% (15 min incubation time), 76 
± 8% (30 min), and 82 ± 4% (50 min). MALDI-TOF: calcd for C38H51N7O9S2 [M]
+
: 813.32, 
found: 813.02; C38H50N7NaO9S2 [M + Na - H]
+
: 835.30, found: 834.90. The “click” product of 
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the reaction between Flu568-acetylene and cRGDfK-azide was quantified by HPLC (yield 75 ± 
3%, 30 min incubation time). MALDI-TOF: calcd for C65H88N14O17S2 [M]
+
: 1400.02, found: 
1400.79; C65H87N14NaO17S2 [M + Na - H]
+
: 1422.57, found: 1422.79. 
Conventional “click” reactions. A Cu(I)-TBTA stock solution was prepared by mixing copper 
sulfate (10 mM, 12.5 µL), sodium ascorbate solution (50 mM, 12.5 µL) and tris[(1-benzyl-1H-
1,2,3-triazol-4-yl)methyl]amine (20 mM, 16 µL). Flu568-azide or Flu568-acetylene (100 µM, 
250 µL) and propargylamine (400 µM, 250 µL) or cRGDfK-azide (600 µM, 250 µL) were mixed 
well, and 60 mol% Cu(I)-TBTA catalyst was added to the reaction solution. The solution was 
shaken and incubated at 37 °C for 15 min (Figure 2.7B) or 30 min (Figure 2.10). The product 
was analyzed by reverse-phase high-performance liquid chromatography. The “click” product of 
the reaction of Flu568-azide and propargylamine was examined by HPLC with yield 12 ± 2%. 
MALDI-TOF: calcd for C38H51N7O9S2 [M]
+
: 813.32, found: 813.94; C38H50N7NaO9S2 [M + Na - 
H]
+
: 835.30, found: 835.78. The “click” product of the reaction of Flu568-acetylene and 
cRGDfK-azide was examined by HPLC with a yield of 54 ± 5%. MALDI-TOF: calcd for 
C65H88N14O17S2 [M]
+





In this work, a new water-soluble TBTA derivative (ligand 2) was synthesized to not only 
chelate and stabilize Cu(I) in the +1 oxidation state for “click” reactions, but also to enable 
immobilization onto a PDMS-glass microreactor. The fabricated “click chip” with immobilized 
Cu(I)-ligand 2 complexes, obviates the need to separate copper species from products, and 
eliminates side reactions of the copper reductant, typically ascorbate, with sensitive 
biomolecules. The Cu(I) catalyst was regenerated on chip five times without losing catalytic 
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efficiency. The model “click” reaction of Flu568-azide and propargylamine was studied on chip 
as a proof-of-principle reaction. The on chip reaction yield reached ~82% with a 50 min 
incubation time at 37 °C. A “click” compatible peptide, cRGDfK-azide, was then reacted with 
the dye Flu568-acetylene, and a yield of ~75% was achieved. These results highlight the 
potential of the “click chip” for the biomolecule-based “click” reactions. 
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“Click chip” for conjugation of bifunctional chelators to 
biomolecules* 
3.1 Introduction
Molecular imaging, the noninvasive visualization of biochemical processes on the sub-cellular 
and cellular levels, is a powerful technique for early detection of diseases and drug discovery.
1
 
Positron emission tomography (PET) and single-photon emission computed tomography 
(SPECT) are currently two widely used clinical molecular imaging modalities. PET and SPECT 
are based on detection of radioisotopes, typically attached to tumor-targeting molecules, which 
are known as “radiotracers”.
2
 Currently, for clinical oncology, cardiology, and neurology one of 













F-based radiotracers have multiple shortcomings including a short half-life 
and lengthy and harsh reaction conditions.
4
 






Zr, have half-lives ranging from 
roughly one hour to a few days. A wide range of available half-lives enables production of 
radiotracers where the half-life of the radioisotope matches the in vivo pharmacokinetics of the 
radiotracer. For example, antibody-based radiotracers may require days to achieve appropriate 
signal-to-noise ratios for imaging, and therefore require a radioisotope with a long half-life. 
Radiometal incorporation into radiotracers is usually accomplished by covalently bonding a 
bifunctional chelator (BFC) to the targeting biomolecule (BM) and chelating a radiometal to the 





Covalent attachment of BFCs is usually accomplished via amide, thiourea, and thioether bonds.
6
 
However, biomolecules tend to have multiple free primary amines and thiols making site-
specific BFC attachment a challenge.
7
 
The advent of “click chemistry”, defined as selective and rapid reactions that require mild 
conditions
8
, has provided a new biorthogonal approach to site-specific BFC attachment to BMs.
9
  
A wide variety of “click” reactions, including Cu(I)-catalyzed azide-alkyne cycloaddition 
(CuAAC)
10
, strain-induced azide-alkyne cycloaddition
11
, and Michael addition of thiols to 
maleimides
12
, have been utilized to link BFCs to BMs. CuAAC is particularly advantageous 
because the reaction is compatible with many functional groups
13
 and the formed triazole 
heterocycle mimics amide bonds
9
 that can also assist with metal chelation
13, 14
. However, key 
challenges for CuAAC chelator conjugation reactions are: (i) the Cu(I) catalyst is cytotoxic
9
, (ii) 
Cu(I) may chelate with BFCs, and (iii) copper ions combined with sodium ascorbate, typically 
used to maintain the copper catalyst in the Cu(I) oxidation state, forms reactive oxygen species 
and byproducts that can damage biomolecules, particularly proteins
15-17
. One convenient method 
to potentially avoid these complications is to immobilize the Cu(I) catalyst on a solid support.  
In this chapter, a microfluidic approach for using immobilized Cu(I) catalyst for CuAAC 
bifunctional chelator conjugation reactions with biomolecules is described. Only a minute 
amount (often nanogram levels
18
) of radiotracer is required for imaging in vivo, but traditionally 
radiotracers are synthesized on relatively large-scale automated synthesis modules that require at 
least 400 μL of solution for easy handling.
19
 Microreactors are promising platforms for 
radiotracer synthesis because they (i) enable handling of small volumes, (ii) provide precise 
control over reaction conditions, (iii) reduce consumption of expensive precursors, and (iv) 
minimize radiation shielding size and radiation exposure to personnel.
20, 21
 To date though, most 
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microfluidic radiotracer research has focused on 
18
F-based probes, in particular the optimization 
of fluorine incorporation.
22





 with radiometals have been demonstrated, and a recent report 
indicated the benefits of using microfluidics for radiotracer quality control analysis
20
. 
The microfluidic approach for conjugating a biomolecule to a bifunctional chelator discussed 
here utilizes a thinner version of the “click chip” discussed in Chapter 2 that features an 
immobilized Cu(I)-ligand complex.
27
 This unique approach integrates the advantages of 
microfluidics (e.g., reduced reagent consumption) and “click” chemistry (e.g., site-specific 
attachment) to yield BM-BFC conjugates. Additionally, an immobilized Cu(I)-ligand complex 
reduces complications associated with Cu(I) catalyst dissolved in solution. The platform was 
validated by synthesizing three different BM-BFC conjugates. Two of the conjugates consisted 
of the azide modified peptide cyclo[Arg-Gly-Asp-D-Phe-Lys] (cRGDfK-azide) conjugated to an 
alkyne derivative of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) (Figure 
3.1A) or 1,4,7-triazacyclononane-1,4-diacetic acid (NO2A) (Figure 3.1B). The third conjugate 
was comprised of the nucleoside 5-ethynyl-2’-deoxyuridine (EdU) conjugated to an azide 




Figure 3.1. Schematic illustration of the BM-BFC conjugates DOTA-cRGDfK (A), NO2A-cRGDfK (B), and DOTA-EdU (C). 
All conjugates include a fully tert-butyl protected BFC without chelated copper ions, but reaction results discussed in detail later 
indicate BFCs in products displayed partial or complete tert-butyl group loss resulting in copper ion chelation. 
 
3.2 Results and discussion 
In this chapter I discuss how a thin “click chip” was utilized for conjugating BFCs and BMs as 
an elegant approach to eventually enable the multi-step synthesis of radiotracers on chip starting 
from initial reagents. To clarify terminology used in this chapter, both Cu(I) and Cu(II) ions were 
utilized in experiments. Cu(I) is the active catalyst for CuAAC bioconjugation reactions. In this 
case, the Cu(I) catalyst was bound to a water soluble Cu(I) ligand to form a Cu(I)-ligand 
complex. The Cu(I) ligand not only immobilizes Cu(I) catalyst, but maintains copper in the +1 
oxidation state critical for CuAAC reactions. However, Cu(II) ions in this work were used to 
chelate copper to BFCs in an effort to reduce loss of immobilized Cu(I) catalyst discussed in 
greater detail in subsequent sections. 
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Multiple LC-MS UV chromatograms (200 nm) will be displayed throughout this chapter. The 
same LC-MS elution method (more details in materials and methods section) was used for all 
samples. Compounds of interest eluted between roughly 12 and 40 min so only this window is 
displayed. There were peaks prior to 12 min elution time, but these were from dimethyl sulfoxide 
(DMSO) and salts and were present because samples were not purified prior to injection into the 
LC-MS system. An example chromatogram of a blank injection with no sample (Figure 3.2A) 
and a sample injection of NO2A-alkyne (Figure 3.2B) is provided to show peak locations of 
salts and DMSO present in most samples. 
 
Figure 3.2. LC-MS UV chromatograms of a blank without any sample (A) and a BFC (NO2A-alkyne) sample (B). The same 
LC-MS method was used for all samples, and all samples had similar peaks from 0-12 min. The large peaks from ~6-12 min are 
due to a small amount of DMSO in samples. 
 
Design and fabrication of thin “click chips” 
The “click chip” for dye conjugation discussed in Chapter 2 was comprised of reservoirs 
containing posts to reduce reagent diffusion times to catalyst sites located on the inner chip 
walls.
27
 Chip features were patterned in polydimethylsiloxane (PDMS) using traditional soft 
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lithography techniques and subsequently bonded to glass. PDMS and glass were used for the 
“click chip” fabrication because of the availability of well-established fabrication procedures and 
facile methods to immobilize compounds onto inner channel surfaces. The same design 
discussed in Chapter 2, five reservoirs with posts, was used for the work described in this chapter 
to provide ample solution volume for analysis. However, most non-therapeutic radiotracers are 
given at nanogram levels.
18
 Here, BFC-BM conjugates were synthesized at roughly microgram 
levels (~100s μM concentrations) for accurate analysis utilizing a LC-MS set-up with a UV 
detector. In addition to reducing reagent concentrations, the number of reservoirs can easily be 
adjusted to tune reactor volume without changing the immobilization process to produce the 
desired nanogram levels of radiotracer with little loss of expensive reagents. 
However, to use the “click chip” approach with immobilized Cu(I) catalyst for the synthesis of 
radiotracers I needed to address the challenge of solvent loss resulting from long incubation 
times in traditional, thick (~3-5 mm) PDMS chips. The previous “click chip” discussed in 
Chapter 2 was well suited for short reactions (~30-50 min), but “click” conjugation of BFCs to 
BMs at or near room temperature require longer incubation times (~12-18 h).
28, 29
 The approach 
taken to alleviate this solvent loss was to create a thinner chip (Figure 3.3A) comprised of three 
layers, glass, PDMS, and cyclic olefin copolymer (COC) (Figure 3.3B). PDMS thickness was 
reduced from approximately 4 mm to 400 μm to minimize solvent loss into the bulk PDMS and 
through the sides of the microreactor. A 100 μm thick layer of water impermeable COC was 
bonded onto the PDMS to minimize water loss through the top of the reactor. Thick PDMS was 




Figure 3.3. Photograph (A) and side-view schematic (B) of a thin “click chip” with five reservoirs filled with posts, the red line 
in (A) is the location of the side-view in (B). PDMS thickness was reduced and a gas impermeable COC layer was added to 
minimize solvent loss. A thicker layer of PDMS was used at inlets and outlets to support tubing. 
 
Control experiments were performed to confirm solvent loss in thin COC/PDMS/glass chips 
was lower compared to traditional thick PDMS/glass chips. Both thin and thick microreactors 
were filled with water and incubated in humidity chambers at room temperature, 37 °C, or 47 °C 
for 12 h. Very little solvent loss occurred in either reactor when incubated at room temperature. 
However, thin chips lost less solvent (6.58% ± 1.12%) compared to thick chips (19.7% ± 3.55%) 
when incubated at 47 °C for 12 h (Figure 3.4). These results confirmed that thin chips reduced 




Figure 3.4. Water loss data for thick PDMS/glass and thin COC/PDMS/glass chips after incubating chips filled with water in a 
humidity chamber for 12 h at the specified temperature. 
 
 
Figure 3.5. Schematic illustration of the water soluble analog of the commonly used Cu(I) chelator tris-
(benzyltriazolylmethyl)amine (TBTA) used here to immobilize Cu(I) catalyst. 
 
The final step for fabrication of thin “click chips” was to immobilize a Cu(I) ligand onto the 
inner microreactor surfaces to enable chelation of Cu(I) catalyst that facilitates the BFC and BM 
“click” conjugation reaction. The Cu(I) ligand utilized here is the same water soluble analog of 
tris-(benzyltriazolylmethyl)amine (TBTA) discussed in Chapter 2 (Figure 3.5), and the 
immobilization process was similar to the method described in Chapter 2.
27
 Briefly, the channel 
surfaces were activated with an acidic hydrogen peroxide solution followed by injection of a neat 
‘silane’ solution. The water soluble Cu(I) ligand was connected to the silane functionalized 
surface using an aza-Michael reaction catalyzed by a borax catalyst. To this end a ligand solution 
consisting of the Cu(I) ligand and borax was then injected into the chip. Finally, a Cu(I) solution 
comprised of an aqueous mixture of CuSO4 and sodium ascorbate was injected into the 
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microreactor to form an immobilized Cu(I)-ligand complex. Excess non-chelated Cu(I)  and 
other ions were removed via rinsing. The amount of chelated Cu(I) catalyst present in 





fabricated thin “click chip” will hereafter be referred to as simply “click chip” for the remainder 
of Chapter 3. 
 
Figure 3.6. LC-MS UV chromatograms of solutions incubated in a “click chip” prior to any surface functionalization (A), after 
silane incubation (B), after attachment of the water soluble Cu(I) ligand (C), and after Cu(I) chelation (D).  
 
Initial conjugation reactions, described in more detail in later sections, indicated some 
contaminants were present in reaction solutions. The contaminants were likely non-immobilized 
reagents from the surface functionalization process. To confirm this two “click chips” were 
functionalized, but the immobilization process was halted at various steps and a buffer solution 
was incubated in the “click chips” and the solutions were collected and analyzed by LC-MS. 
Solutions were collected after four different steps: (1) bonding PDMS device to glass prior to 
any surface treatment steps, (2) silane incubation, (3) water soluble Cu(I) ligand immobilization, 
and (4) Cu(I) incubation. Based on UV chromatograms the primary contaminant was silane 
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(Figure 3.6). This is supported by the observation that silane diffused into the PDMS during the 
functionalization process. The silane then likely leached back into reaction solutions. 
To determine which factors significantly impacted silane contamination a fractional factorial 
design of experiments (DOE) was set-up to tune the parameters of the silane attachment steps. 
The following four factors were varied to reduce the amount of silane diffusing into the PDMS, 
(1) silane concentration, (2) silane incubation time, (3) oven incubation time, and (4) duration of 
methanol rinse following the oven incubation. A fractional factorial design with two levels for 
each factor was selected to quickly determine significant factors. The factors were coded as A, B, 
C, and D and two levels were set for each factor to test the extreme conditions (+ for the upper 
extreme, – for the lower extreme) (Table 3.1). The final fractional factorial DOE consisted of 
eight trials (Table 3.2). 
Table 3.1. Lists all factors and levels used for the fractional factorial DOE to identify significant factors that contribute to silane 
contamination of product solutions. 
Factor and Level Condition 
A- 10% silane 
A+ 97% silane 
B- 5 min silane incubation 
B+ 1 h 55 min silane incubation 
C- 1 h oven incubation 
C+ 24 h oven incubation 
D- 5 min methanol rinse 
D+ 1 h 55 min methanol rinse 
 
Table 3.2. Lists the eight different trials conducted to determine which factors significantly affected silane contamination. The 
plus and minus signs correspond to Table 3.1 and indicate whether the lower or upper extreme was used for a factor. 
 Factors 
Trial A B C D 
1 - - - - 
2 + - - + 
3 - + - + 
4 + + - - 
5 - - + + 
6 + - + - 
7 - + + - 
8 + + + + 
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The eight trials listed in Table 3.2 were performed to determine which factors significantly 
affected silane contamination of product solutions. Each trial represents one microfluidic device 
where the same “click chip” functionalization process was utilized except the procedure stopped 
after rinsing the devices with methanol following silane and oven incubation steps (see materials 
and methods section for details). After the last step an aqueous solution with 8 v/v% DMSO was 
incubated in the chip for 2 hours and the solution was collected for analysis by LC-MS. The 
silane concentrations were calculated based on a standard curve of known silane concentrations 
and the results were entered into Minitab to determine which factors were significant. Based on a 
normal plot of the factors and three two-factor interactions (AB, AC, and AD) none of the effects 
were considered significant (Figure 3.7). 
 
Figure 3.7. Normal plot of factors and three two-factor interactions (AB, AC, and AD) indicated no effects were significant. Plot 




Despite not statistically finding any of the factors significant the LC-MS results indicated trials 
4 and 5 had the highest and lowest silane concentrations (12.1 mM and -0.26 mM respectively) 
of the eight trials. The negative value occurred because the actual silane concentration was below 
the lowest standard (1 mM). The results of trials 4 and 5 made sense considering these treatment 
combinations are the extremes. For example, trial 4 utilized the highest silane concentration 
(97%) and longest silane incubation time (1 h 55 min), but the shortest oven incubation (1 h) and 
methanol rinse (1 h 55 min) times. Trial 5 was the exact opposite of trial 4, representing the 
factors that would likely lead to the lowest silane concentrations in incubation solutions, which 
was supported by values quantified using LC-MS (UV chromatograms). Trials 4 and 5 were 
repeated three more times and the silane concentrations of incubation solutions were determined 
from LC-MS UV chromatograms (Figure 3.8). The lack of any significant factors from the 
fractional factorial design is likely from a lack of replication which is one inherent negative of 
unreplicated fractional factorial DOEs. However, I was able to demonstrate that parameters can 
be tuned to reduce silane contamination of solutions incubated in “click chips”. Future work can 
optimize this process further to optimally minimize silane contamination while maximizing 
bound Cu(I) catalyst. 
 
Figure 3.8. Silane concentration of aqueous solutions incubated in microfluidic devices functionalized using treatment 
combinations of trial 4 or 5 as outlined in Table 3.2. The values represent the average ± one standard deviation (n = 3). 
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BFC and BM conjugation reactions 
General method for conjugation reaction. Prior to the reaction, a reagent mixture was created 
by mixing stock solutions of the appropriate BFC and BM together in a phosphate buffer. Then, 
the “click chip” with immobilized Cu(I) was rinsed and a portion of the BFC and BM solution 
was injected into the microreactor. The microreactor was placed in a pre-heated humidity 
chamber for the specified incubation time, and reaction samples were collected for LC-MS 
analysis. Following sample collection the chip was rinsed thoroughly with methanol and water. 
Then, more BFC and BM solution was injected into the microreactor and incubated in a humidity 
chamber again. The process of adding the reagent mixture, incubating, and collecting a sample 
was repeated until three samples were collected from each “click chip”. The Cu(I) solution 
(CuSO4 and sodium ascorbate) was only injected prior to the first reaction. All conjugation 
reactions were performed on two separate “click chips”, so a total of six samples were collected 
for each set of conjugation reaction parameters. 
LC-MS was utilized to determine the yields of the bioconjugation reactions. No further work-
up of reaction samples was performed prior to LC-MS. All yields discussed here were 
determined from crude reaction samples. Samples were collected from the chip and directly 
injected into the LC-MS system along with multiple dilutions of the initial reagents to establish a 
standard curve. Yields were calculated by comparing peak areas of the initial reagents before and 
after the reaction. 
Unexpected tert-butyl protecting group loss. The initial “click chip” conjugation reaction 
tested was between propargyl-DOTA-tris(tert-butyl) ester and cRGDfK-azide. The reagent 
mixture was incubated for 12 h at 47 °C. DOTA-cRGD product formed but two unexpected 
results occurred; (i) DOTA-alkyne lost tert-butyl (tBu) protecting groups and (ii) DOTA-alkyne 
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chelated copper by removing Cu(I) from the Cu(I)- ligand complex. These two observations 
were true for both unreacted DOTA-alkyne and DOTA in the DOTA-cRGD product. Divalent 
cations have been utilized before to bind near esters in non-BFC compounds to catalyze ester 
hydrolysis, and the rate of hydrolysis was likely related to binding affinities for the divalent 
cation.
30
 Previous reports regarding macrocycle BFCs indicated tBu protected DOTA-alkyne 
species will chelate Cu, but reaction conditions varied widely (e.g., temperature, catalyst 
concentrations) and no previous work used an immobilized Cu(I) catalyst. Previous work 
demonstrated that DOTA-alkyne without tBu protecting groups removes and chelates copper 
from a non-immobilized Cu(I)-ligand complex.
31
 Here, I describe how even when the Cu(I)-
ligand complex is immobilized and the BFC reagent (DOTA-alkyne) contains tBu protecting 
groups, tBu protected DOTA-alkyne still (i) loses tBu protecting groups and (ii) removes Cu(I) 
catalyst from the Cu(I)-ligand complex via chelation. 
 
Figure 3.9. LC-MS UV chromatograms of tBu protected DOTA-alkyne stock solution (A), tBu DOTA-alkyne incubated without 
any metal added (B), tBu DOTA-alkyne incubated with Cu(II) (C), tBu DOTA-alkyne incubated with Ni(II) (D), and tBu DOTA-




To further investigate tBu protecting group loss and metal chelation, tBu protected BFCs were 
incubated with metal ions. A recent review mentioned little systematic data is available on how 
other protected chelators, besides DOTA-alkyne derivatives, behave during CuAAC.
32
 
Therefore, three different protected chelators, including propargyl-DOTA-tris(tBu) ester, were 
incubated with CuSO4 at 47 °C for 4 h to determine the effect of copper ions on different tBu 
protected chelators. Protected DOTA-alkyne displayed complete conversion to Cu-DOTA-
alkyne with 2 t-butyl groups (Figure 3.9), similar to the initial “click” reaction tested. However, 
when an azido-DOTA-tris(tBu) ester compound was incubated under the same conditions, a 
mixture of Cu-DOTA-azide compounds with 2 and 3 tBu protecting groups formed (Figure 
3.10). When incubating copper(II) with a different chelator, propargyl-NO2A-bis(tBu) ester, the 
incubation also yielded a mixture of Cu-NO2A compounds with either 0 or 1 tBu groups (Figure 
3.11). 
The Cu-DOTA-azide compounds are particularly interesting because of the three different 
BFCs incubated with Cu(II), Cu-DOTA-azide with 3 tBu protecting groups was the only 
example of a Cu-BFC complex that formed without loss of any tBu groups. This may be because 
azides are able to assist with formation of Cu complexes.
33
 However, there is little previous 
structural data regarding Cu-DOTA-azide species and further experiments are required to 




Figure 3.10. LC-MS UV chromatograms of tBu protected DOTA-azide stock solution (A) and Cu-DOTA-azide after incubating 
tBu DOTA-azide with Cu(II) for 4 h at 47 °C (B). 
 
Additionally, Ni(II) and Fe(II) were incubated with protected DOTA-alkyne and NO2A-
alkyne to determine the effects of other metals on tBu protected chelators. Ni(II) and Fe(II) were 
selected because both are potential contaminants of 
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Cu solutions. While Ni(II) caused partial or 
complete loss of t-butyl groups similar to Cu(II), incubating DOTA- or NO2A-alkyne with Fe(II) 
caused no substantial loss of t-butyl groups, as seen in Figure 3.9 and Figure 3.11, respectively. 
Therefore, the results indicate that other tert-butyl protected bifunctional chelators, NO2A-
alkyne and DOTA-azide, are also susceptible to (i) tBu protecting group loss and (ii) metal ion 
chelation. Furthermore, the results indicate the number of tBu groups lost depends on the 




Figure 3.11. LC-MS UV chromatograms of tBu protected NO2A-alkyne stock solution (A), tBu NO2A-alkyne incubated without 
any metal added (B), tBu NO2A-alkyne incubated with Cu(II) (C), tBu NO2A-alkyne incubated with Ni(II) (D), and tBu NO2A-
alkyne incubated with Fe(II) (E). 
 
“Click chip” characterization and testing. In light of the tBu loss and chelation issues of tBu 
protected BFCs in the presence of metal ions, even when the metal ion was immobilized, the BM 
and BFC conjugation reaction process was slightly modified. Specifically, BFCs were reacted 
with Cu(II) ions prior to “click” reactions in an effort to reduce loss of Cu(I) catalyst from the 
immobilized Cu(I)-ligand complex. Therefore, all reagent mixtures consisted of the appropriate 
Cu-BFC and BM mixed in a phosphate buffer. 
I systematically tested the conjugation reaction of Cu-DOTA-alkyne and cRGDfK-azide at 
different temperatures (Figure 3.12A) and incubation times (Figure 3.12B) to determine their 
effects on yields. Figure 3.12 displays the yields for each individual reaction for “click chip” 1 
(red columns) and “click chip” 2 (blue columns), and also the cumulative mean yield of all six 
reactions ± one standard deviation (yellow columns) for each condition. Some Cu-DOTA-
cRGDfK yields slightly exceeded 100% due to difficulty in subtracting background levels of the 
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cRGDfK-azide reagent in LC-MS chromatograms. As expected, yields were higher when 
operating at 47 °C compared to 19 °C (Figure 3.12A), especially for the first incubation (left 
most red and blue columns). 
 
Figure 3.12. Yields for successive incubations (i1, i2, i3) of Cu-DOTA-alkyne and cRGDfK-azide performed with “click chips” 
1 (red bars) and 2 (blue bars) incubated at different temperatures (A) or times (B). Reactions at different temperatures (A) were 
incubated for 1 h. Reactions at different times (B) were incubated at 47 °C. Yellow columns represent the cumulative mean yield 
of all six reactions ± one standard deviation for each condition. 
 
Incubation time also affected yields with a general increase in yields with increasing 
incubation time. Yields for “click chip” 2 were considerably lower after 1 h incubations at 47 °C. 
As discussed in Chapter 2, the total amount of immobilized Cu(I) catalyst was 1136 ± 272 
nmol.
27
 Therefore, the difference in yields is likely due to less Cu(I) on “click chip” 2, which is 
further corroborated by Cu(I) loss experiments (Figure 3.14A) discussed in detail later. 
However, yields for both chips after 6 h and 12 h incubations were nearly identical; indicating 
the chip-to-chip variation in Cu(I) catalyst loading had negligible impact on yields for longer 
incubations. 
Control reactions were performed by incubating a solution of Cu-DOTA-alkyne and cRGDfK-
azide in a chip without immobilized silane or water soluble Cu(I) ligand. The Cu(I) solution 
(CuSO4 and sodium ascorbate) was still injected into the microreactors identically to “click 
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chips” but no immobilized water soluble Cu(I) ligand was present. Only a small amount of 
product (8% ± 4%) formed (Figure 3.13), demonstrating the importance of the immobilized 
TBTA analog to first capture the Cu(I) catalyst and then support the Cu(I) oxidation state critical 
for CuAAC reactions. 
 
Figure 3.13. Yields for the conjugation of Cu-DOTA-alkyne and cRGDfK-azide using thin “click chips” with immobilized silane 
and Cu(I) ligand (functionalized) or microreactors without immobilized silane and Cu(I) ligand (not functionalized). Cu(I) 
catalyst was injected into both chips prior to the first reaction. Reactions were incubated for 12 h at 47 °C. 
 
The “click chips” successfully facilitated the conjugation of BFC (Cu-DOTA-alkyne) and BM 
(cRGDfK-azide). Complete conversion of reagents was observed after 6 h incubations at 47 °C 
for the first incubations on both microreactors. These are promising results considering many 
traditional BM and BFC CuAAC conjugation reactions require either harsh reaction conditions, 
including high temperatures and microwave irradiation
28, 31, 34
, or long reaction times (~18 h) at 
room temperature
7
. Additionally, the same two “click chips” were utilized for all reactions and 
similar yields from both microreactors after 6 h and 12 h incubations indicate “click chip” 
fabrication is reproducible. 
Figure 3.12 clearly indicates decreasing yields for successive reactions. The likely cause of 
the decline in yield was active catalyst loss during incubations and rinse steps. To determine the 
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extent of Cu(I) catalyst loss, a solution without BFC or BM was incubated in the “click chips” 
identical to conjugation reactions. Incubation samples were collected similarly to conjugation 
reactions, but methanol and water used to rinse the microreactors after each reaction were also 
collected. The amount of copper (Figure 3.14A) in collected solutions were quantified by 
inductively coupled plasma optical emission spectrometry (ICP-OES). Because ICP-OES 
requires a few milliliters of sample, incubations and rinse solutions were combined in separate 
vials for each chip. Therefore, the results in Figure 3.14A are cumulative amounts of copper for 
each chip after three incubations. 
Despite losing Cu(I) catalyst, most Cu(I) was lost during the rinsing step and both catalytic 
activity and yields were easily recovered by injecting more Cu(I) ions into the microreactor. 
Copper concentrations in samples was low (~20 ppm), which is much lower than typical CuAAC 
“click” conjugation reactions of BFCs and BMs which can easily have copper concentrations in 
the range of 100’s to 1000’s of ppm if not higher. The reduced copper concentration in samples 
mitigates or obviates purification requirements typically required for CuAAC reactions. 
Additionally, Figure 3.14B indicates yields are nearly identical after multiple uses, where one 
use is defined as injection of Cu(I) ions followed by three simultaneous incubations without the 
addition of fresh Cu(I) catalyst in between reactions. The same two “click chips” were used for 
conjugating BFCs and BMs under a variety of conditions but the yields after seven uses (21 
reactions) were nearly the same as the first use (initial three reactions). Figure 3.14B 
demonstrates the robustness of the “click chips” after multiple uses and indicates the 




Figure 3.14. Amount of copper in incubation samples and rinse solutions used to wash the microreactors between incubations. 
The values are the total amount of copper from 3 sequential incubations in each “click chip” (A). Yields of the “click chip” 
facilitated conjugation of Cu-DOTA-alkyne and cRGDfK-azide after one use and seven uses where each “use” consists of 
injecting Cu(I) ions followed by three sequential reactions (B). 
 
Versatility for other substrates. After establishing ideal “click chip” operation conditions with 
the conjugation reaction between Cu-DOTA-alkyne and cRGDfK-azide additional conjugation 
reactions were tested to demonstrate synthesis of different BM-BFC conjugates on chip. Peptides 
are attractive biomolecules for radiotracers because of their rapid clearance and facile 
synthesis
35
, but DNA or RNA based imaging probes are receiving increased attention because of 
their low immunogenicity, high affinity, and stable structures among other traits.
36
 Therefore, 
conjugation reactions between Cu-DOTA-azide and EdU, a commercially available nucleoside, 
were tested to demonstrate a conjugation reaction with a non-peptide BM. There are also a wide 
variety of BFCs besides DOTA utilized in radiotracers. The choice of chelator depends on the 
radiometal utilized
37
, and different chelators can greatly affect biodistribution of radiotracers.
38
  
NO2A derivatives are another widely used BFC, and were utilized for the conjugation reaction 




The “click chip” successfully synthesized both NO2A-cRGD and DOTA-EdU conjugates. 
When Cu-DOTA-azide and EdU were incubated at 47 °C for 12 h in “click chips”, the CuAAC 
conjugation reaction proceeded with similar yields to the Cu-DOTA-alkyne and cRGDfK-azide 
conjugation reaction with near complete conversion and ~80% average yield (Figure 3.15). 
When the Cu-NO2A-alkyne and cRGDfK-azide reaction was performed on chip using the same 
conditions the yields (~45% average yield) were lower than the other two conjugation reactions. 
This indicates longer incubations are likely required for some conjugation reactions (Figure 
3.15). Ultimately, the two additional conjugation reactions demonstrate the versatility of the 
“click chips” to facilitate conjugation reactions between multiple BMs and BFCs. This versatility 
is crucial when synthesizing custom radiotracers to meet the needs of individual patients. 
 
Figure 3.15. Yields for three different CuAAC reactions on chip to produce Cu-BFC-BM conjugates. Reactions were incubated 
at 47 °C for 12 h. 
 
3.3 Materials and methods 
All solvents and chemical reagents were purchased from Thermo Fisher Scientific, Sigma-
Aldrich, or Avantor and were used as received unless otherwise specified. Water was purified in-
house using a Barnstead E-Pure filtration system. Sylgard 184 PDMS from Dow Corning, a 
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G3P-8 Spin Coater from Specialty Coating Systems, silicon wafers from University Wafer, 4 mil 
(101.6 μm) thick COC from TOPAS Advanced Polymers, glass microscope slides from Thermo 
Fisher Scientific, and a PDC-001 Harrick Scientific Plasma Cleaner were utilized for chip 
fabrication. DOTA-alkyne was purchased from CheMatech, and NO2A-alkyne and DOTA-azide 
were from Macrocyclics. The peptide cRGDfK-azide was synthesized as described previously.
31
 
30 gauge PTFE tubing from Cole-Parmer, glass syringes from Hamilton Company or plastic 
syringes from Henke-Sass Wolf and Becton, Dickinson and Company, and Micro-Liter and 
Milliliter syringe pump modules from Harvard Apparatus were used for injecting fluids into 
chips. Cu(I) catalyst loss was determined by a PerkinElmer Optima 2000 DV ICP-OES. LC-MS 
was performed on an Agilent LC-MS (HPLC: 1100, MS: Trap XCT Plus) using a Luna C18(2) 
column (5 μm, 100 Å, 150 x 4.60 mm) from Phenomenex. The same LC-MS method was used 
for all samples. The flow rate was 400 μL min
-1
 with the mobile phase of solvent A (0.1% formic 
acid in water) and solvent B (0.1% formic acid in acetonitrile). The linear gradient used was 0% 
B (0-2 min), 0%→10% B (2-10 min), 10% B (10-15 min), 10%→15% B (15-25 min), 
15%→45% B (25-35 min), 45%→100% B (35-36 min), 100% B (36-51 min), 100%→0% B 
(51-51.5 min), 0% B (51.5-76.5 min). MS (ESI) used a nebulizer pressure of 35.00 psi, a dry gas 
flow rate of 8.00 L min
-1
, a dry temperature of 350 °C, and a capillary voltage of 4.5 kV. 
Thin “click chip” fabrication 
PDMS used for the interconnects was combined in a 10:1 ratio (base : curing agent), mixed, 
and degassed for ~20 min. The PDMS was poured onto a silicon wafer inside a petri dish, and 
cured for 2 h in a 65 °C oven, then allowed to cool to room temperature and stored for later use. 
The silicon masters used for PDMS molds were etched as described previously.
27
 More 10:1 
PDMS was prepared for the microreactor identically to the interconnect process. The etched 
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silicon wafer was centered on a spin-coater, and the degassed PDMS was carefully poured on top 
of the wafer. The PDMS was spun at 200 rpm for 60 s, cured in an oven for 1 h at 65 °C, and 
then allowed to cool to room temperature. A sheet of COC was cut to ~55 x 55 mm. The chip 
design was printed onto a transparency sheet and taped to the COC. Using the transparency sheet 
as a guide the COC above the inlets and outlets was cut out. The cured PDMS prepared earlier 
for interconnects was cut to size using a scalpel. 
The protective coating from the COC was removed and the COC, PDMS interconnects, and 
PDMS chip on the silicon wafer were all placed in a plasma cleaner. All components were 
treated with an oxygen plasma for 1 min. Immediately after removal the PDMS interconnects 
were attached followed by the COC. Pressure was applied to the COC using a block of PDMS to 
remove any air pockets. The bonded components were placed in a 65 °C oven for 30 min then 
allowed to cool to room temperature. A scalpel was used to cut the PDMS along the edge of the 
COC and the PDMS layer was carefully removed from the silicon master. Tape was applied to 
the exposed PDMS surface and the chip was trimmed to size using scissors. The tape was peeled 
off near the interconnect ports and through-holes were punched at each inlet and outlet with a 
piece of 19 gauge hypodermic tubing with the punch side beveled to prevent cracking the PDMS. 
A 50 x 45 x 1 mm glass slide was scrubbed clean with an Alconox solution, rinsed with water, 
and dried with N2. The tape from the PDMS imprint was removed and both the PDMS and glass 
were treated with an oxygen plasma for 1 min. The PDMS and glass were bonded together and 
incubated overnight in a 65 °C oven. 
Quantifying solvent loss in thin and thick chips 
Thick PDMS/glass chips were fabricated as described previously.
27
 Methanol was injected into 
thin (COC/PDMS/glass) and thick (PDMS/glass) chips to eliminate bubbles, and then water was 
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injected for 10 min to replace methanol as the solvent. Double-sided Scotch tape was applied 
onto small pieces of glass (~10 x 10 x 1 mm), which were then placed on top of the interface 
ports of each chip. Microfluidic chips were placed in preheated humidity chambers consisting of 
150 mm diameter glass petri dishes with lids and two aluminum weigh boats filled with water. 
After placing the chips in the glass dishes the lid was sealed with Parafilm. Chips were incubated 
at the appropriate temperature (23 °C, 37 °C, or 47 °C) for 12 h. Water loss was determined by 
comparing chip mass before and after heating. Chips were allowed to cool for at least 10 min 
prior to determining the mass after incubation. 
Ligand immobilization process 
A 1 mL glass syringe and a bottle of 3-(trimethoxysilyl)propyl acrylate (TMSPA), were placed 
in a glove bag to reduce water contamination that may induce silane crosslinking. The glove bag 
was purged with house N2 three times then filled with N2 a fourth time. The syringe was loaded 
with TMSPA inside the N2 filled glove bag. The “click chip” was rinsed with methanol at 30 μL 
min
-1
, and pressure was applied with a block of PDMS to remove any air pockets. Water was 
injected into the microreactor at 30 μL min
-1
 to remove any methanol. During the water injection 
a fresh solution of acidified hydrogen peroxide (5:1:1 H2O/H2O2/HCl by volume) was prepared. 
The “click chip” surfaces were activated by injecting the acidified hydrogen peroxide for 5 min 
at 30 μL min
-1
 then stopping the injection and letting the chip sit for 5 min. Water, then 
methanol, and water again were injected to remove the air pockets produced by the hydrogen 
peroxide solution and remove methanol for further acidic hydrogen peroxide injections. The 
activation process was repeated 3 more times. Three injections may not be required but this was 
done because the hydrogen peroxide solution rapidly develops small bubbles which are trapped 
on chip. Removing bubbles with methanol (other alcohols such as ethanol or isopropanol work 
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well too) in between acidic hydrogen peroxide solution injections may improve the amount of 
the surface activated. 
After the final acidified hydrogen peroxide rinse the microreactor was quickly flushed with 
water then methanol. The syringe of neat TMSPA was removed from the glove bag and silane 
was injected into the microreactor at room temperature for 5 min at 20 μL min
-1
, then the flow 
was reduced to 4 μL min
-1
 for 1 h. The chip was rinsed with methanol then air was injected into 
the chip to remove methanol and the chip was heated in a 65 °C oven for 2 h, and then cooled to 
room temperature. The chip was then rinsed with methanol then water. 
A water-soluble derivative of the Cu(I) ligand tris-(benzyltriazolylmethyl)amine (TBTA) was 
synthesized as described in Chapter 2.
27
 A 20 mM solution of the water-soluble TBTA derivative 
was created by adding 628 μL of water to 8.24 mg (12.6 μmol) of the water-soluble Cu(I) ligand. 
Borax (12.39 mg, 61.57 μmol) was added to the ligand solution to catalyze the aza-Michael 
reaction
39
 that covalently links the ligand with the immobilized TMSPA. The solution was 
placed in a bath sonicator for 10 min. The silane-coated microreactor was rinsed with methanol 
then water followed by injection of the Cu(I) ligand and borax solution at 20 μL min
-1
 for 6 min. 
The tubing was removed and ports covered with Crystal Clear tape, then the microreactor was 
incubated at room temperature for 18 h. More Cu(I) ligand solution was injected followed by a 6 
h incubation at room temperature. After this the chip was rinsed with methanol, water, and air, 
and stored until use for conjugation reactions. 
Minimizing silane contamination 
COC/PDMS/glass chips were functionalized similar to the process described in the ligand 
immobilization process section above, but the procedure was halted after rinsing chips with 
methanol. Four parameters of the silane attachment process were varied as outlined by Table 
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3.2. Aqueous solutions consisting of 8 v/v% DMSO in water were incubated in the devices for 2 
h at 47 °C using the humidified petri dishes as described in the solvent loss section. The 
incubation solutions were collected and analyzed by LC-MS. 
Incubating BFCs with metal ions 
Propargyl-DOTA-tris(tert-butyl) ester or NO2A-butyne-bis(tert-butyl) ester in DMSO, was 
combined with water (2:3 DMSO/water) to create 3.00 mM solutions. Separate 50 mM metal 
stock solutions were prepared by dissolving CuSO4, NiSO4, or FeSO4 in 10 mL of water. In 
separate amber glass vials the appropriate 3.00 mM tBu protected BFC solution (700 μL), 180 
mM potassium phosphate buffer pH 7.20 (175 μL), appropriate 50 mM metal solution (63 μL), 
and water (112 μL) were combined and stirred on a 47 °C hot plate for 4 h along with a control 
vial of tBu protected BFC with additional water added (63 μL) instead of metal solution. A 3.00 
mM solution of azido-mono-amide-DOTA-tris(tert-butyl) ester was prepared identically to 
DOTA-alkyne and NO2A-alkyne and incubated in a similar fashion with a CuSO4 solution so the 
final Cu concentration was 3.00 mM. The solution was incubated for 4 h at 47 °C. Samples were 
analyzed by LC-MS. Multiple products with different quantities of tBu groups may be produced 
after incubating BFCs with metal ions. See Table 3.3 for MS data of metal-BFC complexes. 
Table 3.3. MS (ESI) adduct data for BFCs after incubation with a metal ion. Some incubations formed multiple metal-BFC 
complexes such as NO2A-alkyne and Cu which formed Cu-NO2A-alkyne products with either 0 or 1 tBu protecting groups. 
Compound [M+H]
+
 Adduct Calcd m/z Found m/z 
Cu-DOTA-alkyne (2 tBu) C27H46CuN5O7
+
 615.3 615.4 
Ni-DOTA-alkyne (2 tBu) C27H46N5NiO7
+
 610.3 610.4 
Cu-NO2A-alkyne (1 tBu) C20H33CuN4O5
+
 472.2 471.9 
Cu-NO2A-alkyne (0 tBu) C16H25CuN4O5
+
 416.1 415.8 
Ni-NO2A-alkyne (0 tBu) C16H25N4NiO5
+
 411.1 410.8 
Cu-DOTA-azide (3 tBu) C31H58CuN8O7
+
 717.4 717.0 
Cu-DOTA-azide (2 tBu) C27H49CuN8O7
+




Reaction solution preparation 
cRGDfK-azide was dissolved in DMSO then water was added to make a 3.00 mM solution 
(4:1 water/DMSO). EdU was dissolved in DMSO to create a 6.00 mM stock solution. 2.00 mM 
Cu-BFC solutions were prepared in phosphate buffer as described in the incubating BFCs with 
metal ions section. Reaction solutions were prepared by combining water, phosphate buffer at 
pH 7.20 (30 mM final concentration), the appropriate BM stock solution (600 μM final 
concentration), and Cu-BFC stock solution (400 μM final concentration). 
BFC and BM conjugation reactions 
A Cu(I) solution was created by combining 8.5 mL of water, 0.5 mL of 50 mM CuSO4 
solution, and 1.0 mL of 200 mM sodium ascorbate solution. Chips were rinsed with methanol to 
remove air bubbles then rinsed with water. Cu(I) solution was injected through the side with a 
single interface port for 25 min at 30 μL min
-1
 then allowed to sit for 3 min. Then, Cu(I) solution 
was injected through both ports on the opposite side at 15 μL min
-1
 for 25 min. Water was 
injected for 20 min at 30 μL min
-1
 to rinse the microreactor. The appropriate reagent solution was 
injected into the “click chip" for 5 min at 20 μL min
-1
. Microreactors were incubated in a 
humidified petri dish identically to water loss experiments discussed above. Reaction samples 
were collected by injecting water into the microreactor at 30 μL min
-1
 for 50 s and collecting the 
effluent. Microreactors were rinsed with methanol then water and a second reaction was started 
identical to the first reaction. The process was repeated for a final, third reaction, and 
microreactors were rinsed with methanol, water, and then air was injected to dry the “click 
chips” prior to storage. Cu(I) solution was only injected into microreactors prior to the first 
reaction. Two microreactors were used for each set of reaction parameters for a total of six trials. 
Reaction samples were analyzed by LC-MS and yields were determined by differences in 
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reagent peak areas from LC-MS chromatograms of reaction samples and standards for Cu-
DOTA-cRGDfK (Figure 3.16), Cu-DOTA-EdU (Figure 3.17), and Cu-NO2A-cRGDfK (Figure 
3.18). See Table 3.4 for MS (ESI) data of Cu-BFC-BM conjugates. 
Table 3.4. MS (ESI) adduct data for Cu-BFC-BM conjugates from “click chip” reaction samples. Some reactions formed 
multiple Cu-BFC-BM products with different numbers of tBu groups such as Cu-DOTA-alkyne and cRGDfK-azide which 
formed products with 2, 1, or 0 tBu protecting groups. 
Compound [M+H]
+
 Adduct Calcd m/z Found m/z 
Cu-DOTA-cRGDfK (2 tBu) C54H85CuN16O14
+
 1244.6 1244.9 
Cu-DOTA-cRGDfK (1 tBu) C50H77CuN16O14
+
 1188.5 1188.8 
Cu-DOTA-cRGDfK (0 tBu) C46H69CuN16O14
+
 1132.4 1132.7 
Cu-NO2A-cRGDfK (1 tBu) C47H72CuN15O12
+
 1101.5 1101.6 
Cu-NO2A-cRGDfK (0 tBu) C43H64CuN15O12
+
 1045.4 1045.6 
Cu-DOTA-EdU (2 tBu) C38H61CuN10O12
+
 912.4 913.1 
Cu-DOTA-EdU (1 tBu) C34H53CuN10O12
+
 856.3 857.1 
 
 
Figure 3.16. LC-MS UV chromatograms of a blank without any injection (A), initial Cu-DOTA-alkyne and cRGDfK-azide 
reagent solution prior to reaction (B), and the first sample collected from a reactor after incubating for 12 h at 47 °C (C). The 
peaks at ~15 min and ~21 min are due to silane contamination leaking from the PDMS which can be avoided by proper 





Figure 3.17. LC-MS UV chromatograms of a blank without any injection (A), initial Cu-DOTA-azide and EdU reagent solution 
prior to reaction (B), and the first sample collected from a reactor after incubating for 12 h at 47 °C (C). 
 
 
Figure 3.18. LC-MS UV chromatograms of a blank without any injection (A), initial Cu-NO2A-alkyne and cRGDfK-azide 




Quantifying Cu(I) catalyst loss 
A 9.3 v/v% DMSO solution in water was created to mimic the reagent solution used for “click 
chip” BFC and BM conjugation reactions. Three “reactions” were performed on two 
microreactors identically to the method used for BFC and BM conjugation reactions except 
methanol and water used to rinse the chips following each incubation were collected in addition 
to incubation samples. Samples and rinses were combined in two separate vials for each 
microreactor because ICP-OES requires ~3-5 mL of sample and dilution of individual samples 
may reduce Cu concentration below detection limits. Solvent for each sample was evaporated 
under vacuum then placed in a vacuum oven overnight to ensure removal of all methanol. Nitric 
acid solution (3 mL, 100 mM) was added to each sample. Samples were transferred between 
different vials during processing so a portion of the nitric acid solution was aliquoted to 
previously used vials, vortex mixed, then transferred back to the sample container to reduce Cu 
loss from adsorption to container walls. Samples were diluted with an additional 2 mL of water 
and Cu concentration was quantified for each sample by ICP-OES. The 100 mM nitric acid 
solution was also analyzed and confirmed minimal amounts of Cu (~0.005 ppm) present in this 
solution compared to incubation and rinse samples with Cu concentrations between roughly 0.5-
5 ppm. 
3.4 Conclusions 
Here a thin “click chip” with an immobilized Cu(I) catalyst suitable for CuAAC conjugation 
of biomolecules and bifunctional chelators was developed. The microreactor design was 
improved from the previous “click chip” described in Chapter 2, to reduce solvent loss for longer 
reactions by reducing PDMS thickness and bonding a more gas impermeable COC layer on top 
of the PDMS. Using the new “click chip” design, BM-BFC conjugates using either a peptide, 
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which are easily synthesized and have ideal in vivo clearance characteristics, or a nucleoside, 
representative of the recent interest in DNA or RNA based imaging agents because of their low 
immunogenicity and stable structure were synthesized. Additionally, a wide variety of BFCs are 
utilized in radiotracer synthesis largely depending on the desired radiometal. Three different 
BFC derivatives of DOTA or NO2A, two widely used bifunctional chelators, were used in 
“click” reactions on chip.  The ability to synthesize three different BM-BFC conjugates, without 
potentially harmful microwave irradiation or high temperatures, demonstrates the flexibility of 
the “click chips” to facilitate conjugation reactions under mild conditions. Cu(I) catalyst loss was 
observed but the concentration of copper in reaction samples was minute (~20 ppm), reducing or 
obviating the need to remove copper from reaction solutions, and enabling direct injection of 
crude reaction samples into LC-MS systems.  Thus enabling rapid purification of BFC-BM 
conjugates. 
Additionally, tBu loss from protected BFCs was further explored. Some previous work has 
mentioned hydrolysis of tBu esters from protected BFCs, but the few papers that do discuss tBu 
loss are mostly DOTA-alkyne species. No systematic data exists on how other protected 
chelators respond to CuAAC reaction conditions. The work described here in Chapter 3 
demonstrated that tert-butyl ester hydrolysis occurs for BFCs besides tBu protected DOTA-
alkyne in the presence of metal ions, and that the quantity of tBu protecting groups lost depends 
on the BFC and metal ion. Further work determining the effects of other parameters (e.g., 
temperature) were not studied, but are worthy of further research. 
Due to tBu ester hydrolysis by copper, even when Cu(I) catalyst was immobilized, the BFCs 
chelated Cu(I) catalyst. Therefore, BFC complexes were pre-chelated with Cu(II) ions to reduce 
loss of immobilized Cu(I) catalyst. Copper ions from the Cu-BFC-BM product were not 
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removed. Two general radiometal-based radiotracer production methods using “click” chemistry 
can be used; either chelate then “click” or vice versa. The “click chip” described here will likely 
be useful for chelate then “click” schemes where radiometal chelation occurs prior to 
conjugation to the appropriate BM. This nullifies the need to remove copper ions from the Cu-
BFC-BM product because 
64
Cu or the desired radiometal is already chelated. 
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Design and characterization of a millifluidic herringbone 
mixer* 
4.1 Introduction 
Micro- and millifluidic platforms have been utilized for multiple synthetic applications, 




, and general organic 
and inorganic synthesis
4-6
. In particular, small-scale continuous flow platforms are advantageous 
relative to conventional batch systems due to (i) greater control of reaction parameters (e.g., 
temperature), (ii) simpler scale-up, and (iii) potential for automation.
7
 These small-scale 
continuous flow platforms consist of multiple unit operations such as mixing, chemical 
transformations, and separations.
8
 Off-the-shelf microreactors utilized in continuous flow 
platforms are commercially available and can improve the transition from academic research to 
industrial production while simultaneously reducing the need for expertise and equipment for 
microfabrication.
9
 The continued development of small-scale continuous flow systems and 
individual unit operations will further the adoption of micro- and millifluidic platforms in both 
academia and industry. 
One crucial unit operation used in many small-scale continuous flow systems is mixing, via an 
active or passive approach. Active mixers require an external energy supply (e.g., acoustic 
waves, magnetic fields) to reduce mixing time while passive mixers require only pressure head 
and rely on structures in the mixer to manipulate fluid flow.
10
 The lack of moving parts and/or 
external energy sources makes passive mixers inherently easier to fabricate and operate; 
especially for microfluidic platforms that have a characteristic dimension typically on the scale 
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of 10’s to 100’s of micrometers. Microfluidic passive mixers have been studied extensively over 
the past decades.
10, 11
 However, few efforts have focused on millifluidic mixers.
12
 Millifluidic 
platforms, with characteristic dimensions near 1 mm to a few millimeters, have similar 
advantages to microfluidic platforms such as rapid mass and heat transfer.
5
 Yet, millifluidic 




A wide variety of passive mixer designs have been utilized in microfluidic systems, including 
zigzag channels, 3-D serpentine structures, and slanted wells.
10
 One particular design, the 
staggered herringbone mixer (SHM) developed by Stroock et al.
14
, is frequently utilized in 
microfluidics because of its simple design and proven capability as an efficient mixer for 
continuous flow systems.
15, 16
 The SHM consists of asymmetric grooves that add a transverse 
component to fluid flow that splits, stretches, and folds fluid to reduce diffusion distances and 
subsequently reduce mixing time.
11, 14
 The SHM pattern not only enables rapid mixing, but also 
creates a highly uniform residence time distribution (RTD) similar to a plug flow distribution.
17
 
Determining what has been accomplished at the millifluidic scale is challenging. The term 
“millifluidic” is not as well characterized and utilized as “microfluidic”. For example other terms 
including “milliscale” and “mesofluidic” may be used instead to describe systems near the 
millimeter length scale, and occasionally the term “microfluidic” is still used. A previous scaled-
up SHM was fabricated, but with the herringbone structures sandwiched in between two 
channels instead of on the top or bottom of the channel.
18
  The RTD of the layered herringbone 
device was determined, but mixing efficiency was not quantified and the residence time required 





In this chapter I discuss the development of a millifluidic herringbone mixer capable of rapid 
mixing that is critical for fast reactions to reduce mass transfer limitations. 
Nanoparticle (NP) synthesis is one example reaction that typically requires fast mixing and a 
narrow RTD due to the rapid kinetics of nanoparticle formation and growth. Inhomogeneity in 
mixing during NP synthesis contributes to high polydispersity and poor batch-to-batch 
reproducibility.
19
 Microfluidic platforms have been utilized previously to synthesize NPs 
including a SHM platform.
20, 21
 However, millifluidic platforms are particularly advantageous for 
NP production because of higher throughput and, more critical for metal NP synthesis, reduced 
chance of channel clogging.
13
 Previous work has leveraged the advantages of millifluidic 
continuous flow set-ups for NP synthesis. A turbulent jet mixer was developed for high-
throughput nanoparticle production, but requires a specific flow regime to produce a stable jet.
22
 
Additionally, other previously reported platforms have been based primarily on mixing by 
diffusion with limited mixing in the transversal (perpendicular to fluid flow) direction. Advances 
in mixer design could provide improved control on NP properties such as particle size 
distribution.
13
 A millifluidic SHM capable of faster mixing in the transversal direction relative to 
previous diffusion-based designs that are currently utilized can improve NP synthesis. 
In Chapter 4 I discuss the development and characterization of a simple millifluidic SHM. To 
develop the millifluidic SHM computational fluid dynamics (CFD) simulations were first used to 
optimize the SHM dimensions. The resulting mixer design was readily fabricated using a 
conventional CNC milling machine. The scaled-up SHM was (1) characterized by using aqueous 
dye solutions to confirm mixing capability and (2) validated by synthesizing gold nanoparticles 
(AuNPs) in the mixer to demonstrate one potential application of the millifluidic mixer. 
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4.2 Results and discussion 
The envisioned fabricated millifluidic SHM design would have a similar structure to 
previously constructed microfluidic herringbone mixers for scaled-up mixing and reaction 
applications. The general SHM design consists of individual grooves with one long arm and one 
short arm embedded in the channel at an angle with respect to the channel sidewall. The 
asymmetry of the individual grooves creates two separate helical flows of different sizes. Only 
asymmetric grooves were used for the millifluidic SHM design described in Chapter 4 and the 
terms groove and herringbone are used interchangeably. A set number of individual grooves with 
the same orientation of long and short arms, called a half-cycle, are placed in a row downstream 
of each other. The orientation is then reflected so the short and long arms are on opposites sides 
of the channel to create a second half-cycle (Figure 4.1A). The two half-cycles with opposite 
orientation make one full-cycle, and a typical SHM design contains multiple full-cycles to 
completely mix solutions. The change in orientation between half-cycles alters the center of 





Figure 4.1. Schematics of a channel with herringbones with the number of grooves per half-cycle and spacing between individual 





The mixer design, fabrication, and testing process consisted of CFD simulations, fabricating 
the millifluidic SHMs, characterizing mixing, and validating the mixer design by synthesizing 
nanoparticles. The main goal of CFD simulations was to guide the millifluidic SHM design for 
experimental verification and validation. Three factors, (1) groove width, (2) groove depth, and 
(3) distance between grooves, were varied in CFD simulations to optimize one criterion, extent 
of mixing. Extent of mixing in fabricated millifluidic SHMs was characterized by analyzing the 
mixing of aqueous dye solutions at various flow rates. One potential application of the 
millifluidic SHM was validated by demonstrating synthesis of gold nanoparticles. 
CFD simulations 
A multitude of CFD simulations have been performed to improve groove mixer design, 
including SHMs. Previous simulations analyzed how adjusting variables, especially channel and 
individual herringbone (HB) dimensions (Figure 4.1B), affect mixing. Previously studied 
parameters include channel width (w)
24
, channel height (h)
24, 25





, groove angle relative to the y-axis (θ)
27
, the asymmetry factor (P)
24
, the distance 
between successive grooves (b)
23
, and the number of grooves per half-cycle (Ng)
17
 affect mixing 
performance (Figure 4.1). Other factors not related to channel dimensions (e.g., flow rate) have 
also been tested.
23
 Some previous work has even considered multi-objective optimization with 
two or three criterion (e.g., mixing performance and pressure drop).
24, 26
 However, most prior 
work focused on optimizing microfluidic SHMs with small deviations from the original SHM 
developed by Stroock et al.
23
 
CFD simulations were utilized to optimize HB dimensions for fabrication and experimental 
validation of a millifluidic SHM. For all simulations channel width (800 μm) and channel height 
(200 μm) were held constant to maintain a wetted perimeter (~2 mm) similar to 1/8” stainless 
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steel tubing and 20 gauge PTFE tubing typically used by the Kenis lab. Additionally, the groove 
angle (45°) and asymmetry factor (1/3) were held constant for all simulations because these 
values have been optimized previously and are typically conserved in microfluidic SHM 
simulations.
14, 28
 For this work three factors, groove width (a), groove depth (d), and distance 
between grooves (b), were optimized using CFD simulations. Groove width and groove depth in 
particular are key factors when optimizing mixer performance.
26, 27, 29
 
For this project, three factors were tuned to optimize one criterion, extent of mixing. Previous 
efforts optimized SHM mixers from CFD simulations by analyzing flow-based descriptors (e.g., 
non-axial velocities)
30
, particle tracking techniques
31
, and mixing index
24
 or a similar term, 
coefficient of variation (CoV)
23
. CoV was used to determine the completeness of mixing in both 
CFD simulations and experiments discussed in detail later because this is a commonly utilized 
method for both SHMs and static mixers in general,.
23, 32
 CoV is defined as the ratio of the 
standard deviation of a distribution (e.g., concentration, intensity) by the mean of the 
distribution. CoV values nearer to zero indicate higher uniformity and hence more completely 








Where c is the concentration of the solute, 𝑐̅ is the average concentration, and A is the area of 
the xz-plane analyzed, in this case the channel outlet for all simulations. 
Similar to prior work
23
 the SHM design was optimized in multiple steps: (1) optimize the 
dimensions of a single HB (Figure 4.2A) by adjusting groove width and depth and (2) determine 
ideal distance between two herringbones (Figure 4.3A). For the first step, groove width and 
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groove depth were varied between 200 μm and 800 μm with a step size of 100 μm, and 
simulations of all 49 combinations of groove width and groove depth were performed. Groove 
depth and width were optimized in the single HB simulations here because of their strong impact 
on mixing efficiency.
23, 27




Based on CoV calculations (Equation 4.1) at the channel outlet of single HB simulations the 
optimum groove width was 600 μm (Figure 4.2B). CoV began to increase slightly when groove 
width was increased to 700 μm or 800 μm. Deeper grooves did reduce CoV, but improvements 
in mixing completeness were marginal above groove depths of approximately 400-500 μm 
depending on the groove width (Figure 4.2B). For example, the CoV for a herringbone with a 
groove width of 600 μm and depth of 800 μm was only 0.002 lower than a groove with the same 
width but a depth of 500 μm. Previous work indicated average transversal velocity (used to 
determine mixing effectiveness) did not improve beyond a certain groove depth and width
23
, and 
the CFD simulation results discussed in this chapter showed the same result with a local CoV 
minima achieved by a groove width of 600 μm and groove depth of 800 μm. 
 
Figure 4.2. Image of a COMSOL simulation of a single HB displaying solute concentration that was used to determine optimum 
groove width and groove depth (A) and a surface plot of CoV results, calculated at the channel outlet, from all 49 simulations of 




After optimizing individual groove dimensions, simulations containing two herringbones were 
conducted to optimize the distance between grooves (Figure 4.3A). Herringbone width (600 μm) 
and depth (500 μm) were held constant while the distance between herringbones was altered 
between 200 μm and 1000 μm with a 100 μm step size. A groove depth of 500 μm was chosen to 
reduce computation time and because groove depths greater than 500 μm resulted in marginal 
improvements in single HB mixing effectiveness based on single HB simulations. The CoV at 
the channel outlet of each simulation was calculated using Equation 4.1, and results indicated 
CoV continued to decrease as the distance between herringbones increased (Figure 4.3B). The 
trend of improved mixing for increased distance between grooves is similar to previous work that 





Figure 4.3. Image of a COMSOL simulation with two HBs displaying solute concentration that was used to determine ideal 
distance between grooves (A) and a graph of CoV results, calculated at the channel outlet, from all inter-groove distance 
simulations (B). 
 
However, determining an optimum distance between grooves is more challenging than varying 
distance between two HBs; primarily because another HB can be added for any distance between 
grooves greater than groove width. To demonstrate the effects of adding an additional 
herringbone another simulation was performed with three HBs and 200 μm spacing between 
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grooves (data not shown), holding all other parameters the same as two HB simulations. 
Therefore, the three HB simulation was identical to the two HB simulation with 1000 μm 
spacing between the grooves, except one additional HB was placed in between the two 
herringbones. The CoV of the three HB simulation (0.45) was lower than any of the two HB 
simulations. CoV data from two and three HB simulations indicate that while increased distance 
between grooves reduces CoV, inter-groove distance should not drastically exceed the groove 
width because another HB could be added to the mixer.CFD simulations were used to analyze 
three parameters of a millifluidic SHM: groove width, groove depth, and distance between 
grooves. The results represent a local optimum and additional computational analysis may 
further optimize designs. However, identifying a true optimum is computationally intensive and 
is difficult due to the non-linear nature of the mixing problem
24
, and also because of the number 
of factors involved and potential criterion to optimize. For example, finding a true optimum of 
distance between grooves requires designing a DOE that also varies the total number of HBs, 
number of HBs per half-cycle, groove width, and potentially other factors.  Here though, I 
describe an improved millifluidic SHM design based on CFD simulations that was useful for 
guiding the fabrication of millifluidic SHMs discussed in the next section. 
Fabrication of millifluidic mixers 
Based on the outcomes of the CFD simulations the initial millifluidic SHM design contained 
two inlets, one outlet, and 42 herringbones. Previous work suggested there is not a critical 
number of HBs per half-cycle, but a critical length of each half-cycle.
29
 This was later validated 
by CFD simulations by Sabotin et al., that indicated just two HBs in one half-cycle was enough 
to efficiently stretch and fold mixing fluids.
23
  Therefore, half-cycles consisted of 3 HBs for all 
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millifluidic SHM designs. The initial mixer design contained 42 herringbones to provide ample 
number of cycles to characterize the extent of mixing at different flow rates. 
Millifluidic SHMs were fabricated in poly(methyl methacrylate) (PMMA) by conventional 
milling machines. PMMA was selected because the material is readily machined, has excellent 
optical properties (e.g., low autofluorescence), and is amenable for high-volume device 
production.
33
 A standard CNC milling machine was utilized to fabricate channel and HB features 
in a 3 mm thick blank PMMA sheet. Due to the fabrication method, the mixer dimensions 
differed from optimum CFD simulation dimensions. Groove width was changed to 350 μm 
instead of 600 μm because a 0.014” diameter end mill was utilized for milling the HBs and could 
easily mill each HB in one pass. Additionally, groove depth was reduced to 500 μm because this 
is the maximum depth achievable with this end mill. The milling process also produced HBs 
with rounded corners instead of the sharp corners typically seen in microfluidic SHMs, but 
previous work indicated rounded corners had no negative effects on mixing performance.
23
 
Based on CFD simulations (Figure 4.3B) inter-groove distance was approximately the same as 
groove width. Distance between grooves was ~340 μm for HBs in the same half-cycle and ~400 




Figure 4.4. Dimensions for the short mixer (A), long mixer (B) and herringbones (C). All dimensions are in millimeters. 
 
 
Two different millifluidic SHM designs were fabricated (Figure 4.4, Figure 4.5), and then 
validated by determining the extent of mixing and ability to synthesize AuNPs. The initial 
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millifluidic SHM design with 42 HBs (7 full-cycles), referred to as a “short mixer” (Figure 
4.4A, Figure 4.5A), was bonded to another 3 mm thick sheet of PMMA for quantifying the 
extent of mixing and synthesizing AuNPs. The exact same design was bonded to a thin (175 μm 
thick) sheet of PMMA, to qualitatively analyze mixing completeness in the z-direction with 
confocal microscopy. However, an extended millifluidic SHM was required to enable longer 
residence times for AuNP synthesis, discussed in more detail later. Therefore a new mixer with 
the same channel width, channel height, and individual HB dimensions, but longer channel 
length was fabricated with 156 HBs (26 full-cycles). This SHM, referred to as a “long mixer” 
(Figure 4.4B, Figure 4.5B), was similarly bonded to 3 mm thick sheets of PMMA and utilized 
for both quantifying extent of mixing and synthesizing AuNPs. 
 
Figure 4.5. Photographs of the two different millifluidic SHM designs fabricated in PMMA, the “short mixer” with 42 HBs (7 
full-cycles) and an inset image of one full-cycle of HBs (A) and the “long mixer” with 156 HBs (26 full-cycles) (B). The inset 
image scale bar is 800 μm. 
 
Characterization of millifluidic mixer performance 
Multiple methods have been utilized to characterize the extent of mixing on microfluidic 
platforms including dilution of colored dyes or fluorescent compounds, reactions generating 
colored species, and monitoring species concentration.
34
 In this work two dyes (Fast Green FCF 
and Amaranth) dissolved in phosphate buffered saline (PBS) solution were mixed in the 
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millifluidic SHM devices. Dissolving both dyes in PBS ensures no mismatch in either ionic 
strength or pH. This dye system was adopted from Werts et al. who optimized conditions to use 
Fast Green, Amaranth, and other dyes for quantitative analysis on microfluidic devices with non-
monochromatic light and digital cameras.
35
 A similar technique was used for the work described 
in this chapter to quantify mixing for fabricated millifluidic SHM designs. 
 
Figure 4.6. Photograph of a short mixer and optical microscope images (A) and confocal microscope images (B) at 4 separate 
locations along the channel. Optical microscope images depict mixing of aqueous solutions of Fast Green and Amaranth in the 
xy-plane. Confocal microscope images display mixing of fluorescein and buffer in the xz-plane. Brightness of all confocal 
images was increased by the same amount in Photoshop (v12.1, Adobe Systems Inc.) to improve visualization and no 
quantitative data was extracted from confocal images. The scale bars are 1 cm for the short mixer photograph, 500 μm for optical 
microscope images, and 200 μm for confocal microscope images. 
 
Mixing experiments were performed on the short and long mixers by injecting aqueous 
solutions of Fast Green and Amaranth in separate inlets at equal flow rates (Figure 4.6A). 
Eleven separate images were captured at each imaging location to improve the signal-to-noise 
ratio and minimize the effect of pulses from syringe pumps. ImageJ was utilized to determine 
greyscale intensities across the channel, orthogonal to fluid flow. Analysis of pixel intensity is a 
common method to quantify mixing on chip.
36-38
 Similar to CFD simulations, CoV was again 










where Ii is the intensity of pixel i, 𝐼 ̅is the average intensity, and N is the total number of pixels 
analyzed. For this application a CoV of 0.05 or lower defines a well-mixed solution, which is 
generally accepted in most industrial applications of static mixers.
39
 
Flow rate is an important factor that impacts mixing for SHM designs. Therefore, CoV data 
was gathered after different numbers of full-cycles for multiple flow rates between 0.2 and 4.0 
mL min
-1
 on the short mixer (Figure 4.5A) and 1.0 and 13.0 mL min
-1
 on the long mixer (Figure 
4.5B). See the materials and methods section for details on the experimental set-up and data 
analysis. The initial exponential decay of CoV displayed in Figure 4.7A and B is indicative of 
chaotic mixing and has been shown previously for microfluidic SHMs.
15
 A CoV of less than 0.05 
was achieved in ~100s of milliseconds for short and long millifluidic SHMs, which is 
comparable to previous microfluidic passive mixers.
10
 CoV calculations after the last 
herringbone for short mixers (Figure 4.7C) and long mixers (Figure 4.7D) indicate CoV 
plateaus at roughly 0.03. A similar baseline near a CoV of 0.08 was noticed in previous work 
that quantified mixing in microfluidic SHMs using fluorescent molecules and confocal 
microscopy.
15
 The plateau may be due to edge effects
15
 caused by the different refractive indices 
of PMMA and water or other factors that lead to non-uniform intensity. Edge effects were 
minimized by ignoring ~20 μm of data on either side of the channel, but attempts to reduce 
potential sources of non-uniform intensity to analyze CoVs below 0.03 is unnecessary for most 






Figure 4.7. Graphs of CoV measured after a set number of full-cycles (6 HBs per full-cycle) at different total volumetric flow 
rates in the short mixer (A) or long mixer (B), and graphs of CoV calculated at different total volumetric flow rates after the last 
herringbone in the short mixer (C) or long mixer (D). The dashed line represents a CoV of 0.05, the criteria used to define a well-
mixed solution. Note flow rates represent the total flow rate of both reagents. 
 
Mixing in the z-direction is also important to characterize because the CoV data acquired from 
optical microscope images (Figure 4.6A) are cumulative values over the depth of the channel. 
Confocal microscopy has been utilized previously to analyze mixing in microfluidic SHMs and 
enables visualization of mixing in the z-direction.
14, 15
 In this work a confocal microscope was 
also used to analyze mixing by injecting fluorescein dissolved in phosphate buffer in one inlet 
and phosphate buffer without fluorescein in the second inlet. Cross-sections of confocal images 
(Figure 4.6B) were utilized to qualitatively confirm mixing in the z-direction (see materials and 
methods section for specifics). Quantitative data was not determined primarily because the larger 
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channel size of the millifluidic SHMs relative to microfluidic dimensions required 1s to 10s of 
minutes to capture a single image. Not only is confocal microscopy prohibitively time-
consuming and expensive to analyze multiple flow rates for millifluidic SHMs, but long scan 
times led to non-uniformities in the flow patterns likely due to pulses from syringe pumps. 
However, images of the cross-sections did qualitatively confirm solutions were well-mixed in the 
z-direction. 
Application of millifluidic mixers for nanoparticle synthesis 
Mixing is a key parameter for nanoparticle synthesis. Poor mixing during NP synthesis 
contributes to high polydispersity and poor batch-to-batch reproducibility.
19
 Additionally, RTD 
can affect NP size and negatively impact size distribution.
40
 Therefore, millifluidic SHMs are 
potentially useful for NP synthesis by (1) rapidly mixing reactants and (2) maintaining a narrow 
RTD. Previous work determined the reduction of gold and nucleation for AuNP synthesis can 
occur in less than 100 ms, and specifically noted these results would not have been possible 
without rapid mixing from a micromixer.
41
 Prior work that utilized millifluidic mixers for NP 
synthesis consisted of platforms that mixed primarily by diffusion with slow mixing in the 
transversal direction
13, 42
, utilized a turbulent jet mixer that required a specific flow regime
22
, or 
made a mixer similar to a slanted groove mixer by pressing a Teflon tube with metallic jaws but 
still required turbulent flow to mix solutions properly
43
. Lohse et al. in particular noted the 







Figure 4.8. Hydrodynamic diameter of AuNPs from samples collected from short (blue bars) and long (red bars) mixers at 
different flow rates. Flow rates represent the total flow rate of both reagents. Results are displayed as the mean hydrodynamic 
diameter ± one standard deviation with n = 4. 
 
The millifluidic SHMs were validated by synthesizing AuNPs. Ascorbic acid and chloroauric 
acid were injected in separate inlets of short mixers at the same flow rate and four samples were 
collected at each flow rate. Dynamic light scattering (DLS) results indicated AuNP size 
increased with increasing flow rate (Figure 4.8, blue bars), suggesting incomplete mixing and/or 
too short a residence time depending on the flow rate. For short mixers, a flow rate of 4.0 mL 
min
-1
 resulted in a CoV of ~0.10 measured after the last HB. However, the long mixer displayed 
complete mixing (CoV < 0.05) for flow rates up to 13.0 mL min
-1
 and also enables longer 
residence times in the mixer to reduce AuNP formation in the uncontrolled environment of the 
collection vials. 
Therefore, the same AuNP synthesis experiment was performed utilizing long mixers, and 
AuNP size decreased with increasing flow rate up to 4.0 mL min
-1
 (Figure 4.8, red bars) 
demonstrating the importance of mixing and residence time on AuNP size. Additionally, batch-
to-batch reproducibility improved, indicated by the small deviation in average AuNP size from 
multiple collections at the same flow rate. At a total flow rate of 10.0 mL min
-1
 AuNP size 
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increased similar to the short mixers, indicating device residence time was too short and AuNP 
formation likely continued in the collection vial. Therefore, a longer mixer may be required for 
higher flow rates simply to provide more residence time and not because mixing is incomplete. 
Additionally, the AuNP samples collected at flow rates of 0.2, 0.6, 2.0, or 4.0 mL min
-1
 from the 
long mixer had a polydispersity index (PDI) ranging from 0.18 to 0.26 (Table 4.1) which is 
comparable to similar sized gold nanoparticles from Sigma-Aldrich which have a specified PDI 
of less than or equal to 0.2. 
All millifluidic SHMs utilized in this work displayed gold deposition on channel and HB 
walls. Gold deposition during AuNP synthesis was noted in multiple previous set-ups.
13, 42, 44
 NP 
deposition on channel walls may be advantageous in some cases if the deposited NPs are useful 
as catalysts for continuous flow synthesis.
45
 If NP deposition is undesirable, one of the 
advantages of using polymer-based millifluidic SHMs for NP synthesis is their low cost, and 
millifluidic SHMs can be discarded after generating the desired amount of NPs.
42
 Another 
potential option to reduce deposition is to keep solution pH above 10, but pH also affects AuNP 
size so there is a tradeoff between desired AuNP size and amount of deposition.
43
 Ultimately, 
despite gold deposition on the internal mixer features, the PMMA millifluidic SHMs were still 
capable of producing AuNPs with high batch-to-batch reproducibility and AuNP size could be 
controlled using different flow rates. 
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Table 4.1. Contains all the nanoparticle data used for Figure 4.8, and shows the PDI for each sample as well. A new short or 









Short Mixer 0.2 1 55.3 0.24 
Short Mixer 0.2 2 50.3 0.23 
Short Mixer 0.2 3 49.2 0.22 
Short Mixer 0.2 4 49.4 0.22 
Short Mixer 0.6 1 57.3 0.24 
Short Mixer 0.6 2 56.0 0.25 
Short Mixer 0.6 3 55.8 0.24 
Short Mixer 0.6 4 57.7 0.23 
Short Mixer 2 1 60.1 0.21 
Short Mixer 2 2 61.8 0.21 
Short Mixer 2 3 75.1 0.29 
Short Mixer 2 4 59.2 0.20 
Short Mixer 4 1 71.4 0.28 
Short Mixer 4 2 73.0 0.28 
Short Mixer 4 3 66.6 0.26 
Short Mixer 4 4 75.4 0.29 
Long Mixer 0.2 1 54.5 0.26 
Long Mixer 0.2 2 51.2 0.23 
Long Mixer 0.2 3 54.1 0.24 
Long Mixer 0.2 4 50.4 0.22 
Long Mixer 0.6 1 53.4 0.24 
Long Mixer 0.6 2 52.1 0.23 
Long Mixer 0.6 3 49.5 0.24 
Long Mixer 0.6 4 50.2 0.22 
Long Mixer 2 1 41.7 0.21 
Long Mixer 2 2 40.8 0.21 
Long Mixer 2 3 40.9 0.23 
Long Mixer 2 4 42.0 0.21 
Long Mixer 4 1 39.1 0.21 
Long Mixer 4 2 38.8 0.19 
Long Mixer 4 3 38.9 0.20 
Long Mixer 4 4 38.0 0.18 
Long Mixer 10 1 57.7 0.26 
Long Mixer 10 2 59.6 0.26 
Long Mixer 10 3 58.6 0.23 




4.3 Materials and methods 
All solvents and chemical reagents were purchased from Thermo Fisher Scientific, Sigma-
Aldrich, or Avantor and were used as received unless otherwise specified. Water was purified in-
house using a Barnstead E-Pure filtration system. 
CFD Simulations 
All CFD simulations were completed on a Dell Precision T3500 workstation (Dell Inc.) with 
24 GB of RAM using COMSOL Multiphysics 5.1 (COMSOL Inc.). Two different types of 
simulations were performed. The first set of CFD simulations optimized groove width and 
groove depth using one herringbone while a second set of simulations optimized distance 
between grooves using two, or in one simulation three, HBs. 
CFD simulations used the laminar flow and transport of diluted species interfaces to solve 
Navier-Stokes (NS) equations for incompressible flow and convection-diffusion (CD) equation 
at steady-state. NS and CD equations were coupled for simulations. The density and viscosity of 
the fluid were set to those of water at 20 °C. The material poly(methyl methacrylate) was 
selected for all boundaries, except the inlets and outlet, because PMMA was used for all 
fabricated millifluidic SHMs. 
The channel in all simulations was set to 800 μm wide by 200 μm tall with a 300 μm entry 
length with respect to the apex of the first HB. Channel length was 2000 μm for one HB 
simulations and 3600 μm for two and three HB simulations. For single HB simulations both 
groove width and groove depth were varied from 200 μm to 800 μm with a 100 μm step size, and 
all 49 combinations were simulated. For two HB simulations groove width was 600 μm and 
groove depth was 500 μm while the distance between grooves was varied from 200 μm to 1000 
μm with a 100 μm step size. The single three HB simulation used the same parameters as the two 
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HB simulations except one additional HB was added and the distance between all grooves was 
200 μm. 






) were similar to previous 
work.
23
 The channel entry was split into equal halves for two inlets. Both inlet flows were set to 
0.01 m s
-1
, similar to the velocity of the lower flow rates tested on the fabricated millifluidic 
SHMs. The outlet boundary condition was set to 0 Pa. The solute concentration of one inlet was 
1 mol m
-3
 and the other inlet was 0 mol m
-3
. No slip and no flux boundary conditions were set at 
all other boundaries besides the inlets and outlet. 
Three-dimensional CFD simulations are computationally demanding, especially considering 
the increased size of the channel and herringbones relative to microfluidic SHMs. Therefore the 
meshing was slightly coarser than meshes previously used for microfluidic SHMs
15, 23, 28
 to 
reduce computational power and time. A free tetrahedral mesh was used for both the channel and 
herringbones. Meshing size parameters were 30 μm for the maximum element size, 5 μm for the 
minimum element size, 1.3 for the maximum element growth rate, 0.2 for curvature factor, and 
0.7 for the resolution of narrow regions for the channel and the settings for the herringbones 
were 10 μm, 5 μm, 1.3, 0.2, and 0.85, respectively for a finer mesh relative to the channel. Total 
mesh elements ranged from 7 x 10
5
 to 9 x 10
6
 for single HB simulations, 8 x 10
6
 for two HB 
simulations, and 1 x 10
7
 for the three HB simulation. 
Additionally, to decrease computation time laminar flow was discretized using the default 
COMSOL setting (P1 + P1), and similarly the transport of diluted species utilized the default 
linear discretization. Due to the discretization scheme and to avoid potential convergence issues, 
consistent stabilization (streamline and crosswind diffusion) was utilized, but not inconsistent 
stabilization. Higher order discretization schemes may improve accuracy of simulations, but 
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come at the cost of computation time and power. In this chapter only low Peclet number flows 
were simulated and the mesh used was as fine as possible while still able to complete simulations 
in a timely manner. Streamline and particle tracing are other potential simulation methods to 
determine extent of mixing, but ignore the problem of diffusion.
15
 CFD simulations were used to 
guide SHM design, but extent of mixing was also experimentally determined. All calculations 
and images from CFD simulations were obtained using tools available in COMSOL. 
Millifluidic SHM fabrication 
Two different millifluidic designs were fabricated, a mixer with 42 HBs (Figure 4.4A) and a 
mixer with 156 HBs (Figure 4.4B) referred to as a “short mixer” and “long mixer” respectively. 
All SHM designs were fabricated in 3 mm thick PMMA sheets (Astari Niagra International) 
using a conventional CNC milling machine. A 0.010” diameter end mill was used for milling all 
channels and a 0.014” diameter end mill was utilized for fabricating all herringbones. Fabricated 
HB dimensions were the same for all SHMs (Figure 4.4C). Through holes for inlets and outlets 
were drilled with a 1.20 mm drill bit. The edges around the drilled holes were sanded to remove 
burrs that may impact PMMA bonding, and the PMMA was rinsed with water. 
All millifluidic mixers, except mixers used for confocal microscopy, used a blank 3 mm thick 
piece of PMMA with no milled features as the bottom substrate. The blank was cut slightly 
larger than the PMMA sheet with the milled SHM design. Both blank and milled PMMA sheets 
were scrubbed with an aqueous Alconox solution, rinsed with water, rinsed with isopropanol, 
and finally dried with a stream of nitrogen. Both PMMA sheets were placed in a plasma cleaner 
(Harrick Scientific, model PDC-001) for 2 min at 500 mTorr to reduce bonding temperature and 
improve bonding strength.
46
 The sheets were then quickly combined into the following assembly 
in order from bottom to top: (1) an aluminum block, (2) a sheet of polydimethylsiloxane 
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(PDMS), (3) the blank PMMA sheet, (4) the PMMA piece with milled features, (5) a second 
PDMS sheet, and (6) an aluminum block.  The entire assembly was placed in a hot press (Carver, 
Model 3851) preheated to 95 °C.  A pressure of 2900 kPa was applied for 40 min at 95 °C. The 
hot press was shut off and allowed to cool for 3 h before removing the PMMA device. 
Placement of PDMS sheets, a deformable polymer, on either side of the PMMA pieces 
improved bonding by evenly applying force to the PMMA sheets.  Without PDMS present 
sections of PMMA did not bond.  The PDMS sheets (~15 x 15 cm) were fabricated by pouring a 
degassed 10:1 mixture (base/curing agent) of Sylgard 184 PDMS (Dow Corning) on top of 2 
clean glass plates with walls made from tape to contain the PDMS.  The PDMS was cured 
overnight in a 65 °C oven and removed from the glass plates. 
After bonding, the PMMA surface near the inlets and outlet was cleaned with isopropanol. 
Then NanoPorts (IDEX, 10-32 coned assemblies for 1/16” OD tubing) with gaskets underneath 
were lined up with each inlet or outlet.  The NanoPorts were held in place using a binder clip and 
a 2-part Loctite epoxy was applied around the edges of the NanoPorts.  The epoxy cured 
overnight and then the binder clips were removed. 
The device used for confocal microscopy was a short mixer, and was fabricated in an almost 
identical fashion except a 0.175 mm thick piece of PMMA (Goodfellow) was used for the 
bottom substrate. Additionally, a thin sheet (~0.5 mm) of titanium was inserted between the 
bottom sheet of PDMS and the thin sheet of PMMA to prevent the PDMS from pushing the thin 
PMMA sheet upwards, causing channel collapse. 
General method for injecting solutions into millifluidic SHMs 
All millifluidic SHM devices had NanoPorts glued to both inlets and the outlet for attachment 
of 20 gauge PTFE tubing (Cole-Parmer or AlphaWire) to enable fluid injection and collection. 
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All solutions were loaded into plastic (Becton, Dickinson and Company) or glass (Hamilton 
Company) syringes and connected to the 20 gauge tubing via 20 gauge syringe needles (Becton, 
Dickinson and Company or Hamilton Company). Syringes were placed in milliliter syringe 
pump modules or a PHD 2000 syringe pump (Harvard Apparatus) to control the flow rate of 
injected fluids. Prior to injecting the desired solutions for mixing analysis or nanoparticle 
synthesis, isopropanol then water were injected into the millifluidic mixers to remove any air 
pockets. Air pockets may also be removed with high flow rates of water (~20 mL min
-1
), 
obviating the need for changing the input from isopropanol to water. 
Quantifying the extent of mixing – optical microscope 
A solution of 0.5 mM Fast Green FCF and 2.0 mM Amaranth were prepared in 1x phosphate 
buffered saline from Corning. Fast Green and Amaranth were chosen based on previous work 
that determined these two dyes were useful for characterizing and quantifying microfluidic 
systems with red-green-blue (RGB) cameras.
35
 PBS was used to dissolve the dyes to ensure there 
wasn’t a mismatch in pH or ionic strength between the two different dye solutions.
35
 Prepared 
dye solutions were stored in the fridge (4 °C) in amber glass jars up to 3 months and removed 
approximately 6 to 24 hours before experiments to allow solutions to warm to room temperature. 
Solutions of 0.5 mM Fast Green and 2.0 mM Amaranth were injected at equal flow rates into 
millifluidic SHMs placed on top of a microscope (Leica M205 C) stage and 11 images were 
captured using a RGB camera (Leica DFC295) at five different positions along the length of the 
mixer. During image capture ambient light was reduced by turning off lights and surrounding the 
microscope area with a thick curtain. After capturing all required images, the flow rate was 
changed and the image acquisition process was repeated. Devices were cleaned by injecting 
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isopropanol, then water, and finally air. The entire process of fluid injection and image capture 
was repeated on three separate days for n=3 trials on all graphs in Figure 4.7. 
Each combination of light source, microscope, color camera, and dye solution produces a 
different spectral response and requires checking the concentration range where the response is 
linear.
35
 Therefore, prior to collecting data on the optical microscope to quantify the extent of 
mixing, microscope settings (e.g., zoom, exposure time, gain, saturation, gamma) were 
optimized and linearity of the Fast Green FCF and Amaranth dye solutions checked. 8-bit 
greyscale images were used for image analysis so microscope settings were optimized to ensure 
good separation in greyscale intensity between the two dyes without either dye reaching a 
maxima or minima (i.e., 0 or 255 for 8-bit greyscale images). Linearity of the dyes at all 
concentrations was confirmed by mixing stock solutions of 0.5 mM Fast Green and 2.0 mM 
Amaranth in different concentrations from 100 v/v% Fast Green to 100 v/v% Amaranth and 
injecting the premixed solutions into a millifluidic SHM (Figure 4.9). 
 
Figure 4.9. Graphs without (A) and with (B) linear regression model displaying the linear relationship between the greyscale 
intensity and dye concentration. Data is expressed as the mean ± standard deviation (A) or all data points are displayed (B). Both 
graphs are displayed to show the small standard deviation in greyscale intensity (A) and to accurately calculate a simple linear 




Captured images were analyzed by ImageJ (v1.48v, National Institutes of Health) to 
quantitatively determine the extent of mixing. Images were split into 8-bit red, green, and blue 
channels, and the red channel was saved for processing. A line was drawn across the channel, 
orthogonal to the fluid flow, and a single column of intensity values was gathered from the line 
for each red channel image, ignoring ~20 μm of data on either side of the channel to avoid edge 
affects. Lines were drawn in between half-cycles to ensure no collected data came from a 
herringbone feature (Figure 4.10). The coefficient of variation (CoV) was calculated (Equation 
4.2) at each position imaged (11 images per position) using Microsoft Excel (Microsoft 
Corporation). The same number of data points was used for each CoV calculation. Home-written 
scripts (ImageJ) and macros (Excel) were used to accelerate image processing and analysis. 
 
Figure 4.10. Schematic to demonstrate how greyscale intensity data was collected from optical microscope images. The raw 
optical microscope images were split into 8-bit red, green, and blue channels, and the red channel was preserved for analysis. A 
line was drawn across the channel (red line in image), perpendicular to fluid flow, to determine the greyscale intensity values in 
ImageJ. Further data processing was performed in Excel to remove data from ~20 μm on either side of the channel to avoid edge 




Characterizing the extent of mixing – confocal microscope 
A 50 mM potassium phosphate buffer solution was prepared and the pH was adjusted to 8.00. 
A stock solution of 50 mM fluorescein was prepared in dimethyl sulfoxide.  A 500 μM solution 
of fluorescein was created by diluting 50 mM fluorescein stock solution in 50 mM phosphate 
buffer, pH 8.00. 500 μM fluorescein and 50 mM phosphate buffer were injected into different 
inlets of a millifluidic SHM at a flow rate of 100 μL min
-1
 for each fluid (200 μL min
-1
 total flow 
rate). Z-stack images were captured using a LSM 700 confocal microscope (Carl Zeiss Inc.) with 
a 20x/0.8 Plan-Apochromat objective and a 488 nm laser. A tile scan with 2 tiles was necessary 
to capture the full width of the channel so the final dimensions of the z-stack images were 
approximately 1132 μm (x) x 566 μm (y) x 210 μm (z). Slices from the confocal images 
representing the xz-plane were obtained using Imaris x64 software (v8.1.2, Bitplane). 
Gold nanoparticle synthesis and characterization 
A 6 mM ascorbic acid solution and a 0.375 mM chloroauric acid solution were prepared in 
water immediately prior to nanoparticle synthesis experiments.  Ascorbic acid and chloroauric 
acid were injected into separate inlets at equal flow rates.  A new millifluidic SHM was used for 
each flow rate.  Four separate 4 mL samples were collected at each flow rate, waiting 30 s before 
collecting the first sample and waiting 1 min between each subsequent collection.  A Malvern 
Zetasizer Nano-ZS (Malvern Instruments) was used to determine the hydrodynamic diameter of 
gold nanoparticles using DLS.  The mean hydrodynamic diameter and standard deviation were 
determined using the 4 separate samples collected at each flow rate. 
4.4 Conclusions 
Millifluidic platforms have similar advantages to their microfluidic counterparts, including 
rapid heat and mass transfer, but use of millifluidics enables higher throughput and millifluidic 
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platforms are simpler to fabricate and operate than their microfluidic equivalents. One crucial 
step in many applications is mixing, which has been well characterized for the microfluidic scale 
but not for the millifluidic scale. CFD simulations were used to identify the dimensions (groove 
width, groove depth, and distance between grooves) that optimize the mixing performance of a 
millifluidic staggered herringbone mixer. Based on insights from the CFD simulations, a short 
millifluidic mixer was fabricated and quantitatively characterized, and results indicated the mixer 
was able to rapidly and effectively mix (CoV < 0.05) fluids up to a total flow rate of ~2.0 mL 
min
-1
. A similar long mixer with more HBs was able to successfully mix solutions at flow rates 
of 13.0 mL min
-1
. 
One potential use of the millifluidic SHM design was validated by synthesizing AuNPs. The 
short mixer displayed larger AuNP size with increasing flow rate and poorer batch-to-batch 
reproducibility likely from a combination of incomplete mixing and short residence time. 
However, the long mixer design demonstrated (1) improved batch-to-batch reproducibility 
compared to the short mixer, (2) size control by adjusting total flow rate, and (3) PDIs similar to 
commercially available AuNPs. In summary, the millifluidic SHM design discussed in Chapter 4 
is an inexpensive, easily manufactured platform that can be used to rapidly mix solutions for NP 
synthesis and potentially other applications including pharmaceutical production, enzymatic 
reactions, and improving chemical selectivity of reactions. 
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Molecular imaging has the potential to improve the understanding of biochemical processes 
and assist with clinical diagnoses and disease treatment. The molecular imaging technique 
positron emission tomography (PET) in particular has grown substantially in the field of clinical 
oncology since the 1990s.
1







, but despite the widespread use of [
18
F]FDG the probe has multiple shortcomings 
including a lack of sensitivity for specific tumors, and the radioisotope 
18
F has a short half-life. 
There is a strong desire to further the development and production of other PET radiotracers, 
specifically radiotracers that utilize radiometals because radiometal-based radiotracers offer 
flexibility, modularity, and simplicity.
3
 
In my dissertation I first described how microfluidic platforms and “click chemistry” can be 
used to improve synthesis of radiometal-based PET radiotracers. Typically, PET radiotracers are 
produced in large batches (approximately a few milliliters) and then shipped to the imaging 
location. While this centralized production approach may be cost effective, the method is not 
conducive to personalized medicine. Recently, there has been a rise in the interest of producing 
the most suitable PET radiotracer (personalized medicine), on-site (decentralized production), 
when needed (dose-on-demand), to enable more individualized treatment of patients.
4
 The 
continued development of microfluidic platforms for radiotracer synthesis is essential to the 
development of the decentralized, dose-on-demand production approach. Reducing reactor size 
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The goal of personalized medicine is to further divide one general population of patients into 
smaller strata to improve diagnosis and treatment while minimizing side effects. Molecular 
imaging agents, especially PET radiotracers, can non-invasively image tumors without disrupting 
the body’s biochemistry or physiology and assist with determining which patients will respond to 
specific treatments. However, cancer is heterogeneous in nature and a multitude of molecular 
targets exist for molecular probe development including integrins, vascular endothelial growth 
factor (VEGF), and cyclooxygenase (COX)-2.
7
 The wide range of targets requires an equally 
large number of specific biomolecules for incorporation into PET radiotracers. Improving the 
synthesis of tumor-specific radiotracers and molecular imaging agents in general is necessary for 
the continued growth of personalized medicine. For example, more than 1,400 
18
F-based tracers 
have been developed for research applications, but few are commercially available due to high 
capital and operating costs and short radiotracer half-life.
6
 
The “click chip” was designed to address the challenge of producing multiple radiotracers with 
different biomolecules using one chemistry to simplify the synthesis process. “Click chemistry”, 
specifically Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC), enables site-specific 
attachment of bifunctional chelators (BFCs) to the tumor-targeting biomolecules (BMs) under 
mild reaction conditions unlikely to denature biomolecules (e.g., proteins
8
). The fabricated “click 
chip” leverages the advantages of microfluidics and CuAAC to improve the BFC and BM 
conjugation process while also reducing purification requirements by immobilizing the cytotoxic 
Cu(I) catalyst, minimizing or obviating the need to remove Cu(I). I demonstrated the ability to 
synthesize three different BM-BFC conjugates with minimal Cu(I) leaching (~1 μg) into the 
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product solution. Furthermore, many CuAAC biomolecule and bifunctional chelator conjugation 
reaction conditions require long incubation times
9
 or high temperatures (~80-100 °C) and 
microwave irradiation
10
. Here, I demonstrated the ability to synthesize a peptide and BFC 
conjugate at 47 °C in high yields (~80% – 100%) after 1-6 hours. 
Nanoparticles are also useful as molecular imaging agents with the potential to easily 
incorporate multiple modalities (e.g., theranostics
11
). Many nanoparticles (NPs) have been 




, and Fe3O4 NPs
15
. 
However, NPs are currently synthesized using batch synthetic strategies that are not easily scaled 
up.
16-18
 Lohse et al. addressed this issue by creating a simple millifluidic reactor to produce gold 
nanoparticles (AuNPs) in a high throughput fashion, but specifically mentioned the current 
design was a “version 1.0” model and one potential improvement would be to incorporate new 
mixer designs.
16
 Rapid mixing is critical for NP synthesis because poor mixing contributes to 
high polydispersity and poor batch-to-batch reproducibility.
19
 
In addition to the development of a “click chip”, in this dissertation I describe the development 
of a millifluidic staggered herringbone mixer (SHM) to improve the throughput of nanoparticle 
synthesis. While microfluidic platforms have been utilized previously to synthesize nanoparticles 
with high monodispersity
19
, production of nanoparticles using millifluidics is still relatively new. 
Therefore, computational fluid dynamics (CFD) simulations were utilized to optimize the mixer 
design which was then fabricated by milling the features in sheets of poly(methyl methacrylate) 
(PMMA). Optical and confocal microscopy both confirmed the fabricated mixer was able to 




Overall my dissertation focused on the development of micro- and millifluidic platforms to 
improve the synthesis of imaging agents. In Chapter 2 I described how a new water-soluble Cu(I) 
ligand was covalently attached to the walls of a microfluidic platform to enable immobilization 
and stabilization of Cu(I) to reduce purification requirements of “click” reactions. The fabricated 
“click chip” was validated by conjugating a dye with a small molecule and peptide. Chapter 3 
discussed how the “click chip” was improved by reducing the polydimethylsiloxane (PDMS) 
thickness and bonding a thin sheet of cyclic olefin copolymer (COC) to reduce solvent loss and 
enable longer reactions on chip. Three different BM-BFC conjugates were synthesized on the 
thin “click chip” to demonstrate the potential of the thin “click chip” for producing radiometal-
based PET radiotracers. In Chapter 4, I described the development of a millifluidic SHM for 
reactions that require rapid mixing, such as NP synthesis. The millifluidic SHM was validated by 
synthesizing AuNPs. 
5.2 Future directions 
The developed “click chip” was successfully utilized to produce three separate BM-BFC 
conjugates with miniscule amounts of Cu(I) catalyst in the product solution. While two different 
BMs (a peptide and a nucleoside) were utilized for these conjugation reactions further work can 
demonstrate the utility of the “click chip” to synthesize other BM and BFC conjugates including 
antibody conjugates
8
 using one chemistry to simplify radiotracer production. Additionally, by 
using a microfluidic platform the consumption of expensive of reagents and radiation shielding 
costs may be reduced; improving the availability of a “click chip” system for the decentralized 
production of radiotracers with dose-on-demand capabilities. 
One “click chip” conjugation reaction created a product in relatively low yields (~65%) after 
12 h indicating some reaction conditions may need to be further optimized. The same ratio of 
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reagents (1:1.5 BFC / BM) was used for all reactions to validate the “click chip”, but reagent 
ratios could be adjusted to improve yields with reduced reaction time. Additionally, only one 
Cu(I) ligand was utilized for “click chips”. Cu(I) ligands can impact reaction rates
8
, and testing 
the “click chip” concept with different Cu(I) ligands may improve reaction rates as well. 
Additionally, further work can focus on the loss of tert-butyl (tBu) protecting groups from 
BFCs. As mentioned in Chapter 3, tBu groups were removed from BFCs during “click reactions” 
and also when incubated with metal ions. The extent of tBu loss depended on the metal ion and 
the BFC. Further work examining the tBu loss phenomena could provide insights on improving 
the harsh reaction conditions (e.g., strong acids) typically required for de-tert-butylation. Evans 
et al. also recently noticed how a simple copper salt could be used to remove tBu groups from 
amides under mild conditions.
20
 Furthermore, the loss of tBu groups indicates that a chelate then 
“click” strategy as opposed to a “click” then chelate strategy may be most effective when using 
the “click chip” for PET radiotracer synthesis, and further work can validate this premise. 
With regards to the millifluidic SHM for NP production, only AuNPs have been produced 
using the mixer. These nanoparticles were only analyzed using dynamic light scattering (DLS) 
and further characterization (e.g., transmission electron microscopy) can confirm the size 
distribution of the synthesized nanoparticles. Future work could determine the utility of the 
mixer for synthesizing other nanoparticles including micelles and polymersomes. A 
commercially available microfluidic SHM has been utilized previously to synthesize polymeric 
nanoparticles but the throughput was low (10s – 100s μL/min).
21
 A millifluidic turbulent jet 
mixer has also been utilized to synthesize lipid and polymer NPs
22
, but requires achieving a 
specific flow regime to achieve rapid mixing which may be difficult when changing solvents 
and/or solutes. Further work studying the synthesis of polymer and lipid vesicle formation using 
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the millifluidic SHM described in my dissertation could demonstrate the potential to create 
imaging agent and therapeutic NPs at a greater throughput (1s – 10s mL/min) relative to 
microfluidic platforms. 
Another potential future research avenue is to further analyze the millifluidic mixer design. 
Microfluidic mixers have been well-studied the last decades, but little work has focused on the 
mixing performance of millifluidic mixers.
23
 Here we only identified a local optimum by tuning 
three different parameters, herringbone width and depth and the distance between herringbones. 
Identifying a true optimum is computationally intensive and difficult due to the non-linear nature 
of the mixing problem
24
, and also because of the number of factors involved and potential 
criterion to optimize. Further computational and experimental work expanding the design space 
to include other factors such as the channel height and width and the number of grooves per half-
cycle could further improve the millifluidic SHM mixing effectiveness. Additionally, other 
mixer designs analyzed at the microfluidic scale (e.g., slanted groove mixer
25
) can be further 
studied at the millifluidic scale to determine the effect of design on mixing effectiveness. 
Additionally, sometimes capping agents are added to nanoparticles to control NP size and 
shape
26, 27
, promote catalytic performance of NPs
28
, or bind specific biological analytes
29
. The 
addition of different capping agents to the NP synthesis process could be tested on the 
millifluidic SHM by mixing the capping agent directly with the reagents or adding another 
port(s) downstream to attach capping agents to already synthesized NPs. 
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